UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 10-Q

(Mark One)
/X/ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended OCTOBER 2, 2005

/ / TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934

Commission File Number 333-17827-01

ISP CHEMCO INC.
(Exact name of registrant as specified in its charter)

DELAWARE 51-0382622
(State or Other Jurisdiction of (IRS Employer
Incorporation or Organization) Identification No.)

300 DELAWARE AVENUE, SUITE 303, WILMINGTON, DELAWARE 19801
(Address of principal executive offices) (Zip Code)

(302) 427-5818
(Registrant's telephone number, including area code)

NONE
(Former Name, Former Address and Former Fiscal Year,
if Changed Since Last Report)

-----------------------------------
See Table of Additional Registrants

Indicate by check mark whether the registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days. Yes /X/ No / /

Indicate by check mark whether the registrant is an accelerated
filer (as defined in Rule 12b-2 of the Act). Yes / / No /X/

Indicate by check mark whether the registrant is a shell company (as
defined in Rule 12b-2 of the Exchange Act). Yes // No /X/

As of November 16, 2005, 100 shares of the registrant's common stock (par
value $.01 per share) were outstanding. There is no trading market for the
common stock of the registrant. As of November 16, 2005, each of the additional
registrants had the number of shares outstanding which is shown on the table
below. There is no trading market for the common stock of the additional
registrants. No shares of the registrant or the additional registrants are held
by non-affiliates.

THE REGISTRANT AND THE ADDITIONAL REGISTRANTS MEET THE CONDITIONS SET FORTH
IN GENERAL INSTRUCTIONS H(1)(a) AND (b) OF FORM 10-Q AND ARE THEREFORE FILING
THIS FORM WITH THE REDUCED DISCLOSURE FORMAT.

ADDITIONAL REGISTRANTS

Address, including zip
Commission File code and telephone
Exact name of registrant as State or other No. of No./ I.R.S. number, including area
specified in its charter jurisdiction of Shares Employer code, of registrant's
incorporation or Outstanding Identification No. principal executive
organization offices
- --------------------------- ---------------- ----------- ------------------ -------------------------

ISP Chemicals Inc. Delaware 10 333-70144-08/ Route 95 Industrial Area,
22-3807357 P.O. Box 37
Calvert City, KY 42029
(270) 395-4165

ISP Minerals Inc. Delaware 10 333-70144-07/ 34 Charles Street
22-3807370 Hagerstown, MD 21740
(301) 733-4000

ISP Technologies Inc. Delaware 10 333-70144-09/ 4501 Attwater Avenue
22-3807372 and State Highway 146
Texas City, TX 77590
(409) 945-3411

PART I - FINANCIAL INFORMATION
ITEM 1 - FINANCIAL STATEMENTS

ISP CHEMCO INC.

CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)
(THOUSANDS)

THIRD QUARTER ENDED NINE MONTHS ENDED
---------------------- ---------------------
OCTOBER 2, OCTOBER 3, OCTOBER 2, OCTOBER 3,
2005 2004 2005 2004
---------- ---------- --------- ----------

Net sales........................... $ 294,426 $ 252,773 $ 866,229 $ 781,338
Cost of products sold............... (204,381) (166,648) (573,252) (502,270)
Selling, general and administrative. (48,969) (47,990) (149,370) (146,721)
Other operating charges............. (3,863) - (14,395) -
Amortization of intangible assets... (353) (336) (1,021) (775)
--------- --------- --------- ---------
Operating income.................... 36,860 37,799 128,191 131,572
Interest expense.................... (14,851) (13,333) (42,862) (40,892)
Interest income..................... 568 508 1,683 1,495
Other expense, net.................. (2,829) (1,212) (12,411) (5,343)
--------- --------- --------- ---------
Income before income taxes.......... 19,748 23,762 74,601 86,832
Income taxes........................ (6,791) (8,321) (25,376) (30,213)
--------- --------- --------- ---------
Net income.......................... $ 12,957 $ 15,441 $ 49,225 $ 56,619
========= ========= ========= =========

The accompanying Notes to Consolidated Financial Statements are an
integral part of these statements.

ISP CHEMCO INC.

CONSOLIDATED BALANCE SHEETS (UNAUDITED)
(DOLLARS IN THOUSANDS, EXCEPT PER SHARE AMOUNTS)

OCTOBER 2, DECEMBER 31,
2005 2004
----------- -----------
ASSETS
Current Assets:
Cash and cash equivalents.......................... $ 19,556 $ 32,939
Accounts receivable, trade, less allowance of
$6,920 and $6,794 at October 2, 2005 and
December 31, 2004, respectively.................. 136,219 105,737
Accounts receivable, other......................... 35,998 21,464
Receivables from related parties................... 16,180 15,186
Inventories........................................ 239,505 191,735
Deferred income tax assets......................... 29,351 14,833
Prepaid expenses................................... 7,559 6,973
--------- ----------
Total Current Assets............................. 484,368 388,867
Property, plant and equipment, net................... 621,698 599,085
Goodwill, net of accumulated amortization of $180,486 340,020 337,794
Intangible assets, net of accumulated amortization of
$3,280 and $2,259 at October 2, 2005 and
December 31, 2004, respectively.................... 18,546 18,677
Long-term receivable from related party.............. 35,575 34,043
Other assets......................................... 79,124 64,450
---------- ----------
Total Assets......................................... $1,579,331 $1,442,916
========== ==========

LIABILITIES AND SHAREHOLDER'S EQUITY
Current Liabilities:
Short-term debt................................... $ 71 $ 71
Current maturities of long-term debt.............. 2,848 2,932
Accounts payable.................................. 86,110 65,799
Accrued liabilities............................... 86,296 84,549
Income taxes payable.............................. 55,353 56,484
---------- ----------
Total Current Liabilities....................... 230,678 209,835
---------- ----------
Long-term debt less current maturities.............. 685,868 649,368
---------- ----------
Deferred income tax liabilities..................... 130,723 122,822
---------- ----------
Other liabilities................................... 88,093 88,961
---------- ----------
Shareholder's Equity:
Common stock, $.01 par value per share;
1,000 shares authorized; 100 shares issued
and outstanding ................................ - -
Additional paid-in capital........................ 446,530 327,763
Retained earnings................................. - 36,542
Accumulated other comprehensive income (loss)..... (2,561) 7,625
---------- ----------
Total Shareholder's Equity...................... 443,969 371,930
---------- ----------
Total Liabilities and Shareholder's Equity.......... $1,579,331 $1,442,916
========== ==========

The accompanying Notes to Consolidated Financial Statements are an
integral part of these statements.

ISP CHEMCO INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)
(THOUSANDS)

NINE MONTHS ENDED
-----------------------
OCTOBER 2, OCTOBER 3,
2005 2004
---------- ----------

Cash flows from operating activities:
Net income.......................................... $ 49,225 $ 56,619
Adjustments to reconcile net income to net cash
provided by operating activities:
Impairment of fixed assets...................... 10,532 -
Depreciation.................................... 52,149 47,944
Amortization of intangible assets............... 1,021 775
Noncash interest charges........................ 1,510 1,604
Deferred income taxes........................... (6,617) 20,471
Increase in working capital items................... (65,224) (40,472)
Proceeds from sale of accounts receivable........... 2,820 3,930
Increase in receivables from related parties........ (2,526) (5,201)
Other, net.......................................... 928 945
--------- ---------
Net cash provided by operating activities............. 43,818 86,615
--------- ---------
Cash flows from investing activities:
Capital expenditures and acquisitions............... (125,118) (74,940)
--------- ---------
Net cash used in investing activities................. (125,118) (74,940)
--------- ---------
Cash flows from financing activities:
Decrease in short-term debt......................... - (1)
Proceeds from issuance of debt...................... - 31,188
Proceeds from borrowings under revolving
credit facilities................................. 215,800 126,150
Repayments of borrowings under revolving
credit facilities................................. (177,800) (126,150)
Repayments of long-term debt........................ (1,742) (2,229)
Loans from related party............................ - 15,000
Increase in loan to related party................... - (7,760)
Debt issuance costs................................. - (1,725)
Dividends to parent company......................... (107,000) (67,163)
Capital contributions from parent company........... 140,000 -
--------- ---------
Net cash provided by (used in) financing activities... 69,258 (32,690)
--------- ---------
Effect of exchange rate fluctuations on cash
and cash equivalents................................ (1,341) (165)
--------- ---------
Net change in cash and cash equivalents............... (13,383) (21,180)
Cash and cash equivalents, beginning of period........ 32,939 56,426
--------- ---------
Cash and cash equivalents, end of period.............. $ 19,556 $ 35,246
========= =========

The accompanying Notes to Consolidated Financial Statements are an
integral part of these statements.

ISP CHEMCO INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - (CONTINUED)
(THOUSANDS)

NINE MONTHS ENDED
----------------------
OCTOBER 2, OCTOBER 3,
2005 2004
---------- ----------

Supplemental Cash Flow Information:

Cash paid during the period for:
Interest (net of amount capitalized)................ $ 51,467 $ 49,566
Income taxes (including taxes paid pursuant to
the Tax Sharing Agreement)....................... 31,517 16,173

Acquisitions:
Estimated fair market value of assets acquired...... $ 30,722 $ 30,421
Purchase price of acquisitions...................... 30,005 27,280
-------- --------
Liabilities assumed................................. $ 717 $ 3,141
======== ========

Supplemental disclosure of financing activities:

In April 2004, the Company declared dividends totaling $106.2 million to its
parent company, International Specialty Holdings Inc., including cash dividends
paid of $67.2 million. In connection with these dividends, the Company's total
long-term loan receivable of $39.0 million from a related party was eliminated.

The accompanying Notes to Consolidated Financial Statements are an
integral part of these statements.

ISP CHEMCO INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

The consolidated financial statements for ISP Chemco Inc. (the "Company")
reflect, in the opinion of management, all adjustments necessary to present
fairly the financial position of the Company and its consolidated subsidiaries
at October 2, 2005, and the results of operations and cash flows for the three-
and nine-month periods ended October 2, 2005 and October 3, 2004. All
adjustments are of a normal recurring nature. Certain amounts in the 2004
consolidated financial statements have been reclassified to conform to the 2005
presentation. These consolidated financial statements should be read in
conjunction with the annual consolidated financial statements and notes thereto
included in the Company's Annual Report on Form 10-K for the fiscal year ended
December 31, 2004 filed with the Securities and Exchange Commission on March 31,
2005 (the "2004 Form 10-K").

NOTE 1. NET SALES

Included in net sales for the third quarter and nine months ended October
2, 2005 are $4.5 million of revenues associated with technology licensing
activities. The costs associated with such activities have been included in cost
of products sold.

NOTE 2. OTHER OPERATING CHARGES

The Company has implemented a program for the restructuring and
consolidation of production capacity in the food ingredients product line within
the specialty chemicals business segment. In March 2005, the Company entered
into a long-term supply contract with an international company for the purchase
of a product in the specialty chemicals business that the Company currently
manufactures at its San Diego, California alginates plant. Accordingly, the
Company performed an impairment review in the first quarter of 2005 and recorded
a $10.5 million non-cash fixed asset impairment charge related to the San Diego
facility. The impairment charge was determined based on a review of anticipated
future cash flows related to this facility compared with the carrying value of
the facility's fixed assets.

In the fourth quarter of 2004, the Company decided to transfer certain
production assets in its food ingredients product line from a leased facility in
England to its plant in Girvan, Scotland and accrued $0.5 million for related
severance costs. The Company announced in June 2005 that it would be closing the
San Diego alginates plant in 2006 and transferring the manufacturing of many of
its San Diego-produced alginates products to the Girvan plant. In the third
quarter of 2005, the Company recognized charges of $3.9 million related to the
closings of the San Diego plant and the leased facility in England. These
charges included $1.8 million related to lease terminations, $1.2 million for
severance costs and $0.9 million for other site exit costs. Additional expenses
expected to be recognized related to these costs over the next nine months is in
a range of $2.0 million to $4.0 million. The liability at October 2, 2005
included in "Accrued liabilities" related to these plant closings was $2.6
million.

ISP CHEMCO INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) - (CONTINUED)

NOTE 3. COMPREHENSIVE INCOME (LOSS)

Third Quarter Ended Nine Months Ended
--------------------- ------------------------
October 2, October 3, October 2, October 3,
2005 2004 2005 2004
--------- --------- ---------- ---------
(Thousands)

Net income.................................. $ 12,957 $ 15,441 $ 49,225 $ 56,619
--------- --------- --------- ---------
Other comprehensive income (loss),
net of tax:
Foreign currency translation adjustment.. (398) 2,783 (10,186) (669)
--------- --------- --------- ---------
Total other comprehensive loss.............. (398) 2,783 (10,186) (669)
--------- --------- --------- ---------
Comprehensive income........................ $ 12,559 $ 18,224 $ 39,039 $ 55,950
========= ========= ========= =========

Changes in the components of accumulated other comprehensive income (loss)
for the nine months ended October 2, 2005 are as follows:

Cumulative Additional
Foreign Minimum Accumulated
Currency Pension Other
Translation Liability Comprehensive
Adjustment Adjustment Income (Loss)
---------- ---------- -----------
(Thousands)
Balance, December 31, 2004....... $ 16,229 $ (8,604) $ 7,625
Change for the period............ (10,186) - (10,186)
---------- --------- ---------
Balance, October 2, 2005......... $ 6,043 $ (8,604) $ (2,561)
========== ========= =========

NOTE 4. INVENTORIES

Inventories comprise the following:

October 2, December 31,
2005 2004
--------- ------------
(Thousands)
Finished goods................ $126,951 $109,366
Work-in-process............... 53,503 34,665
Raw materials and supplies.... 59,051 47,704
-------- --------
Inventories................... $239,505 $191,735
======== ========

At October 2, 2005 and December 31, 2004, $70.0 million and $60.4 million,
respectively, of domestic inventories were valued using the LIFO method. If the
FIFO inventory method had been used for these inventories, the value of
inventories would have been $11.9 million and $4.0 million higher at October 2,
2005 and December 31, 2004, respectively.

ISP CHEMCO INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) - (CONTINUED)

NOTE 5. GOODWILL AND INTANGIBLE ASSETS

Goodwill represents the excess of the purchase price of an acquired
enterprise or assets over the fair value of the identifiable assets acquired and
liabilities assumed. Through December 31, 2001, the Company amortized goodwill
and certain other intangible assets on a straight-line basis over the expected
useful lives of the underlying assets. In accordance with the provisions of
Statement of Financial Accounting Standards ("SFAS") No. 142, "Goodwill and
Other Intangible Assets," effective January 1, 2002, goodwill is no longer being
amortized over its estimated useful life. However, as required by SFAS No. 142,
tests for impairment of goodwill are performed on at least an annual basis, or
at any other time if events occur or circumstances indicate that the carrying
amount of goodwill may not be recoverable. The impairment testing is performed
in two steps: (i) the Company determines impairment by comparing the fair value
of a reporting unit with its carrying value; and (ii) if there is an impairment,
the Company measures the amount of impairment loss by comparing the implied fair
value of goodwill with the carrying amount of that goodwill.

To determine the fair value of each reporting unit, the Company utilizes a
combination of an "income" approach and a "market value" approach. With the
"income" approach, the Company develops a discounted cash flow analysis based
upon budgets and projections reviewed and utilized by the Company's management.
In addition to the projected cash flow, the Company develops an appropriate
terminal value based on the operating results for the last year in the
projection. Second, the Company develops a "market value" approach to value each
reporting unit, utilizing profitability data of comparable publicly traded firms
in each industry and compares the reporting unit with those independent firms.
The two methods are then correlated based on the relevance and reliability of
the two approaches.

Other intangible assets are being amortized over their useful lives. The
useful life of an intangible asset is based on management's assumptions
regarding the expected use of the asset and other assumptions. If events or
circumstances indicate that the life of an intangible asset has changed, it
could result in higher future amortization charges or recognition of an
impairment loss.

The following schedule reconciles the changes in the carrying amount of
goodwill, by business segment, for the nine months ended October 2, 2005.

Specialty Industrial Mineral Total
Chemicals Chemicals Products Goodwill
--------- ---------- -------- ---------
(Thousands)

Balance, December 31, 2004........ $ 286,255 $ - $ 51,539 $ 337,794
Valuation adjustment - payment of
contingent consideration........ 1,282 - - 1,282
Translation adjustment............ 944 - - 944
--------- ---------- --------- ---------
Balance, October 2, 2005.......... $ 288,481 $ - $ 51,539 $ 340,020
========= ========== ========= =========

The following is information as of October 2, 2005 and December 31,
2004 related to the Company's acquired intangible assets:

ISP CHEMCO INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) - (CONTINUED)

NOTE 5. GOODWILL AND INTANGIBLE ASSETS - (CONTINUED)

October 2, 2005 December 31, 2004
Range of ---------------------------- ---------------------------
Amortizable Gross Carrying Accumulated Gross Carrying Accumulated
Lives Amount Amortization Amount Amortization
(Dollars in Thousands)

Intangible assets subject to amortization:
Patents............................... 5-20 years $ 669 $ (212) $ 669 $ (170)
Formulations.......................... 5-10 years 2,740 (569) 2,740 (295)
Unpatented technology................. 8-15 years 2,240 (186) 1,350 (75)
Customer base......................... 10-15 years 2,348 (293) 2,348 (151)
Non-compete agreements................ 2- 5 years 3,419 (1,896) 3,419 (1,469)
EPA registrations..................... 5 years 166 (124) 166 (99)
-------- -------- -------- --------
Total amortizable intangible assets.. 11,582 (3,280) 10,692 (2,259)
Intangible assets not subject
to amortization:
Trademarks............................ 5,596 - 5,596 -
EPA registrations..................... 4,648 - 4,648 -
-------- -------- -------- --------
Total unamortizable intangible assets 10,244 - 10,244 -
-------- -------- -------- --------

Total intangible assets................... $ 21,826 $ (3,280) $ 20,936 $ (2,259)
======== ======== ======== ========

Estimated amortization expense:
Year ending December 31, (Thousands)
---------
2005................................................ $ 1,382
2006................................................ 1,447
2007................................................ 1,183
2008................................................ 1,183
2009................................................ 885

NOTE 6. RELATED PARTY TRANSACTIONS

During the second quarter of 2005, the Company amended its management
agreement (the "Management Agreement"), effective January 1, 2005, whereby the
Company, through a subsidiary, provides certain general management,
administrative, legal, telecommunications, information and facilities services
to Building Materials Corporation of America ("BMCA"), an affiliate,
International Specialty Products Inc. ("ISP"), International Specialty Holdings
Inc., the Company's parent company, ISP Investco LLC, and ISP Synthetic
Elastomers LP. The purpose of the amendment was to adjust the management fees
payable by the parties under the Management Agreement. Charges by the Company
for the year 2005 for providing such services under the amended Management
Agreement will aggregate approximately $24.9 million. Charges by the Company for
providing such services are reflected as reductions of "Selling, general and
administrative" expenses in the Consolidated Statements of Operations.

In addition, during the second quarter of 2005, a subsidiary of the Company
entered into a management services agreement with Heyman Properties, LLC and
Heyman Investment Associates Limited Partnership (collectively, the "Heyman
Entities"), effective as of January 1, 2005. The term of the management services
agreement is from January 1, 2005 through December 31, 2005, and may be renewed
for additional one-year terms. Under the agreement, the Company will provide
certain general management services, and the Heyman Entities will provide
certain advisory services for specified fees. The Company will receive a net
amount of approximately $0.3 million related to these services in 2005.

ISP CHEMCO INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) - (CONTINUED)

NOTE 7. BENEFIT PLANS

Defined Benefit Plans

The Company provides a noncontributory defined benefit retirement plan
for certain hourly employees in the United States (the "Hourly Retirement
Plan"). At several locations, new employees may not participate and benefits
have been frozen for most participants. Benefits under this plan are based on
stated amounts for each year of service. The Company's policy is to fund this
plan consistent with the minimum funding requirements of ERISA.

ISP Marl GmbH, a wholly-owned German subsidiary of the Company, provides
a noncontributory defined benefit retirement plan for its hourly and salaried
employees (the "ISP Marl Plan"). Benefits under the ISP Marl Plan are based on
average earnings over each employee's career with the Company.

The Company's net periodic pension cost for the third quarter and first
nine months of 2005 and 2004 for the Hourly Retirement Plan included the
following components:

Third Quarter Ended Nine Months Ended
--------------------------- -------------------------
October 2, October 3, October 2, October 3,
2005 2004 2005 2004
---------- ---------- ---------- ----------
(Thousands)

Service cost............................. $ 48 $ 69 $ 144 $ 207
Interest cost............................ 531 523 1,594 1,569
Expected return on plan assets........... (763) (736) (2,289) (2,208)
Amortization of actuarial losses......... 152 126 455 378
Amortization of unrecognized prior
service cost........................... 61 60 182 180
------- ------- ------- -------
Net periodic pension cost................ $ 29 $ 42 $ 86 $ 126
======= ======= ======= =======

The Company's net periodic pension cost for the third quarter and first
nine months of 2005 and 2004 for the ISP Marl Plan included the following
components:

Third Quarter Ended Nine Months Ended
--------------------------- --------------------------
October 2, October 3, October 2, October 3,
2005 2004 2005 2004
---------- ---------- ---------- ----------
(Thousands)

Service cost............................. $ 32 $ 23 $ 96 $ 69
Interest cost............................ 55 48 165 144
Amortization of actuarial losses......... 4 - 12 -
Amortization of unrecognized prior
service cost........................... 1 1 3 3
------- ------- ------- -------
Net periodic pension cost................ $ 92 $ 72 $ 276 $ 216
======= ======= ======= =======

Postretirement Medical and Life Insurance

The Company generally does not provide postretirement medical and life
insurance benefits, although it subsidizes such benefits for certain employees
and certain retirees.

The net periodic postretirement benefit (income) cost for the third
quarter and first nine months of 2005 and 2004 included the following
components:

ISP CHEMCO INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) - (CONTINUED)

NOTE 7. BENEFIT PLANS - (CONTINUED)

Third Quarter Ended Nine Months Ended
-------------------------- -------------------------
October 2, October 3, October 2, October 3,
2005 2004 2005 2004
--------- ---------- ---------- ----------
(Thousands)

Service cost............................. $ - $ (9) $ - $ 8
Interest cost............................ 70 75 210 281
Amortization of actuarial gains.......... (37) (33) (112) (66)
Amortization of unrecognized prior
service cost........................... (88) (71) (263) (213)
------- ------- ------ ------
Net periodic postretirement benefit
(income) cost.......................... $ (55) $ (38) $ (165) $ 10
======= ======= ====== ======

Long-Term Incentive Plans

The Company has two long-term incentive plans, the 2000 Long-Term
Incentive Plan and the 2003 Executive Long-Term Incentive Plan, which provide
long-term compensation to executives, key management personnel and certain other
employees based on ISP's "Book Value" (as defined in the plans). The value of
incentive units granted under the plans is determined at the end of each fiscal
quarter based on ISP's total Shareholder's Equity. The value on the date of
grant is compared to the value as remeasured at the end of each quarter in order
to determine compensation expense. Compensation expense related to these plans
was $0.8 and $1.3 million for the third quarter of 2005 and 2004, respectively,
and $6.3 and $7.1 million for the first nine months of 2005 and 2004,
respectively.

NOTE 8. BUSINESS SEGMENT INFORMATION

Third Quarter Ended Nine Months Ended
--------------------- ----------------------
October 2, October 3, October 2, October 3,
2005 2004 2005 2004
--------- --------- --------- ----------
(Millions)

Net sales:
Specialty Chemicals....................... $ 179.1 $ 168.7 $ 548.6 $ 533.0
Industrial Chemicals...................... 75.2 50.5 197.7 148.3
Mineral Products (1)...................... 40.1 33.6 119.9 100.0
--------- --------- --------- ---------
Net sales................................... $ 294.4 $ 252.8 $ 866.2 $ 781.3
========= ========= ========= =========

Operating income (loss):
Specialty Chemicals (2)................... $ 24.0 $ 33.8 $ 96.8 $ 121.6
Industrial Chemicals...................... 8.4 (0.7) 16.3 (2.3)
Mineral Products.......................... 4.7 5.5 15.7 13.6
--------- --------- --------- --------
Total segment operating income............ 37.1 38.6 128.8 132.9
Unallocated corporate office.............. (0.2) (0.8) (0.6) (1.3)
--------- --------- --------- ---------
Total operating income...................... 36.9 37.8 128.2 131.6
Interest expense, interest income and
other expense, net ..................... (17.2) (14.0) (53.6) (44.8)
--------- --------- --------- ---------
Income before income taxes.................. $ 19.7 $ 23.8 $ 74.6 $ 86.8
========= ========= ========= =========

ISP CHEMCO INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) - (CONTINUED)

NOTE 8. BUSINESS SEGMENT INFORMATION - (CONTINUED)

(1) Includes sales to BMCA and its subsidiaries of $27.0 million and $24.2
million for the third quarter of 2005 and 2004, respectively, and $81.9
million and $73.3 million for the first nine months of 2005 and 2004,
respectively.

(2) Operating income for the Specialty Chemicals business segment for the third
quarter and first nine months of 2005 include $3.9 million and $14.4
million, respectively, of other operating charges related to a program for
the restructuring and consolidation of production capacity in the food
ingredients product line, including a $10.5 million non-cash charge for the
impairment of fixed assets. See Note 2.

NOTE 9. ACQUISITION

In March 2005, the Company acquired a 1,4-butanediol ("BDO") production
facility in Lima, Ohio, and related working capital. BDO is a key building block
for many of the core specialty chemicals that the Company markets for
pharmaceutical, personal care, food, beverage, coatings, oil field and other
market applications. The preliminary purchase price of the acquisition has been
allocated to the estimated fair value of the assets acquired pending the
determination of any additional contingent consideration. This acquisition is
not expected to be material to the Company's results of operations in 2005.

NOTE 10. RECENT ACCOUNTING PRONOUNCEMENTS

In November 2004, the Financial Accounting Standards Board ("FASB") issued
SFAS No. 151, "Inventory Costs," an amendment of Accounting Research Bulletin
("ARB") No. 43, Chapter 4, which discussed the general principles applicable to
the pricing of inventory. SFAS No. 151 amends ARB No. 43, Chapter 4, to clarify
that abnormal amounts of idle facility expense, freight, handling costs, and
spoilage should be recognized as current-period charges. In addition, SFAS No.
151 requires that allocation of fixed production overheads to the costs of
conversion be based on the normal capacity of the production facilities. SFAS
No. 151 will be effective for inventory costs incurred during fiscal years
beginning after June 15, 2005. The Company does not expect the adoption of SFAS
No. 151 to have a material effect on the Company's consolidated financial
statements.

In December 2004, the FASB issued SFAS No. 153, "Exchanges of Nonmonetary
Assets," an amendment of Accounting Principles Board ("APB") Opinion No. 29.
SFAS No. 153 eliminates the exception from fair value measurement for
nonmonetary exchanges of similar productive assets and replaces it with an
exception for exchanges that do not have commercial substance. A nonmonetary
exchange has commercial substance if the entity's future cash flows are expected
to significantly change as a result of the exchange. SFAS No. 153 will be
effective for nonmonetary asset exchanges occurring in fiscal reporting periods
beginning after June 15, 2005. The Company does not expect the adoption of SFAS
No. 153 to have an immediate effect on the Company's consolidated financial
statements.

In December 2004, the FASB issued a revised SFAS No. 123 ("SFAS No. 123R"),
"Share-Based Payment." SFAS No. 123R requires that the cost resulting

ISP CHEMCO INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) - (CONTINUED)

NOTE 10. RECENT ACCOUNTING PRONOUNCEMENTS - (CONTINUED)

from all share-based payment transactions be recognized in the financial
statements. SFAS No. 123R establishes fair value as the measurement objective in
accounting for share-based payment arrangements and requires all entities to
apply a fair-value-based measurement method in accounting for share-based
payment transactions with employees. In February 2003, the Company's indirect
parent company, International Specialty Products Inc. ("ISP") completed a going
private transaction. As a result, stock-based compensation plans were terminated
and payments were made in accordance with the terms of the merger agreement. In
addition, the Company currently accounts for incentive units granted to eligible
Company employees pursuant to ISP's 2000 Long-Term Incentive Plan and the 2003
Executive Long-Term Incentive Plan under the accounting prescribed by FASB
Interpretation No. ("FIN") 28, "Accounting for Stock Appreciation Rights and
Other Variable Stock Option and Award Plans." FIN 28 requires an entity to
measure compensation as the amount by which the Book Value (as defined in the
plans) of the incentive units covered by the grant exceeds the option price or
value specified of such incentive units between the date of grant and the
measurement date, resulting in a change in the measure of compensation for the
right or award. Since compensation expense related to such incentive units is
currently included in the actual Consolidated Statement of Operations, the
Company does not expect SFAS No. 123R to have an impact on the Company's
consolidated financial statements.

In December 2004, the FASB issued FASB Staff Position ("FSP") Nos. FAS
109-1 and FAS 109-2, each as a result of the passage in October 2004 of the
American Jobs Creation Act of 2004 (the "Jobs Act"). FSP No. FAS 109-1 relates
to a provision in the Jobs Act that provides a tax deduction of up to nine
percent (when fully phased-in) on qualified production activities. The FASB
indicated in FSP No. FAS 109-1 that this deduction should be accounted for as a
special deduction in accordance with SFAS No. 109, "Accounting for Income
Taxes," rather than as a tax rate reduction. This FSP was effective upon
issuance. The Company does not expect the adoption of this FSP to have a
material effect on its 2005 consolidated financial statements.

FSP No. FAS 109-2 relates to a provision in the Jobs Act that introduces a
special one-time dividends received deduction on the repatriation of certain
foreign earnings to a U.S. taxpayer, provided certain criteria are met. This FSP
was effective upon issuance. This FSP will not have an impact on the Company's
consolidated financial statements.

ISP CHEMCO INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) - (CONTINUED)

NOTE 10. RECENT ACCOUNTING PRONOUNCEMENTS - (CONTINUED)

and therefore an ARO would be reasonably estimable if either of the following
conditions exist: (a) the settlement date and method of settlement for the ARO
have been specified by others, such as by law, regulation or contract or (b) the
information is available to reasonably estimate the settlement date or the range
of potential settlement dates, the method of settlement, and the probabilities
associated with the potential settlement dates and methods of settlements. FIN
47 will be effective for the Company as of December 31, 2005. The Company is
currently reviewing its AROs to determine the potential impact of FIN 47 on its
consolidated financial statements, and, at this time, the Company does not
believe that FIN 47 will have a material impact on the Company's consolidated
financial statements.

In May 2005, the FASB issued SFAS No. 154, "Accounting Changes and Error
Corrections." SFAS No. 154 eliminates the requirement in APB Opinion No. 20,
"Accounting Changes," to include the cumulative effect of changes in accounting
principles in the Consolidated Statement of Operations in the period of change.
Instead, SFAS No. 154 requires that changes in accounting principles be
retrospectively applied, whereby the new accounting principle is applied to
prior accounting periods as if that principle had always been used. SFAS No. 154
also redefines "restatement" as the revision of previously issued financial
statements to reflect the correction of an error. SFAS No. 154 is effective for
accounting changes and corrections of errors made in fiscal years beginning
after December 15, 2005, although early adoption is permitted for accounting
changes and correction of errors made after the date SFAS No. 154 was issued.
SFAS No. 154 does not change the transition provisions of any existing
accounting pronouncements. The Company will adopt the provisions of SFAS No. 154
as of January 1, 2006.

NOTE 11. GUARANTOR FINANCIAL INFORMATION

In 2001, the Company and three of its 100% owned subsidiaries jointly
issued, in three separate transactions, a total of $405.0 million aggregate
principal amount of 10 1/4% Senior Subordinated Notes due 2011 (the "2011
Notes"). The 2011 Notes are guaranteed by all of the Company's domestic
subsidiaries, other than certain immaterial subsidiaries and the Company's
accounts receivable financing subsidiary. These guarantees are full,
unconditional and joint and several.

ISP Global Technologies Inc., which is a guarantor of the 2011 Notes, is
party to a License and Royalty Agreement with non-guarantor foreign affiliates.
Under this agreement, ISP Global Technologies granted a license to certain
non-guarantor foreign affiliates for the use of the patent rights, know-how and
trademarks in connection with the manufacture, use and sale of the Company's
products.

Presented below is condensed consolidating financial information for the
Company, the guarantor subsidiaries and the non-guarantor subsidiaries. This
financial information should be read in conjunction with the consolidated
financial statements and other notes related thereto.

ISP CHEMCO INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) - (CONTINUED)

NOTE 11. GUARANTOR FINANCIAL INFORMATION - (CONTINUED)

ISP CHEMCO INC.
CONDENSED CONSOLIDATING STATEMENT OF OPERATIONS
THIRD QUARTER ENDED OCTOBER 2, 2005
(THOUSANDS)

Non-
Parent Guarantor Guarantor
Company Subsidiaries Subsidiaries Eliminations Consolidated
-------- ------------ ------------ ------------ ------------

Net sales ................................ $ - $ 136,636 $ 157,790 $ - $ 294,426
Intercompany net sales ................... - 69,860 3,651 (73,511) -
------- ---------- ---------- ---------- ----------
Total net sales ....................... - 206,496 161,441 (73,511) 294,426
------- ---------- ---------- ---------- ----------
Cost of products sold .................... - (166,984) (110,908) 73,511 (204,381)
Selling, general and administrative ...... - (28,334) (20,635) (48,969)
Other operating charges................... - (1,663) (2,200) (3,863)
Amortization of intangible assets......... - (353) - (353)
------- ---------- ---------- ---------- ----------

Operating income ......................... - 9,162 27,698 - 36,860
Equity in income of subsidiaries.......... 13,993 - - (13,993) -
Intercompany royalty income (expense)..... - 19,625 (19,625) -
Intercompany dividend income ............. - 1,709 - (1,709) -
Interest expense ......................... 1,037 (16,102) 214 (14,851)
Interest income .......................... - 52 516 568
Other expense, net ....................... (1) (2,124) (704) (2,829)
------- ---------- ---------- ---------- ----------
Income before income taxes ............... 15,029 12,322 8,099 (15,702) 19,748
Income taxes ............................. (363) (1,007) (5,421) (6,791)
------- ---------- ---------- ---------- ----------
Net income ............................... $14,666 $ 11,315 $ 2,678 $ (15,702) $ 12,957
======= ========== ========== ========== ==========

ISP CHEMCO INC.
CONDENSED CONSOLIDATING STATEMENT OF OPERATIONS
THIRD QUARTER ENDED OCTOBER 3, 2004
(THOUSANDS)

Non-
Parent Guarantor Guarantor
Company Subsidiaries Subsidiaries Eliminations Consolidated
------- ------------ ------------ ------------ ------------

Net sales................................. $ - $ 118,097 $ 134,676 $ - $ 252,773
Intercompany net sales.................... - 61,187 4,471 (65,658) -
------- ---------- ---------- ---------- ----------
Total net sales........................ - 179,284 139,147 (65,658) 252,773
------- ---------- ---------- ---------- ----------
Cost of products sold..................... - (132,049) (100,257) 65,658 (166,648)
Selling, general and administrative....... - (28,826) (19,164) (47,990)
Amortization of intangible assets......... - (336) - (336)
------- ---------- ---------- ---------- ----------

Operating income.......................... - 18,073 19,726 - 37,799
Equity in income of subsidiaries.......... 16,465 - - (16,465) -
Intercompany royalty income (expense)..... - 9,953 (9,953) -
Intercompany dividend income.............. - 1,436 - (1,436) -
Interest expense.......................... 635 (14,031) 63 (13,333)
Interest income .......................... - 23 485 508
Other expense, net........................ (1) (1,146) (65) (1,212)
------- ---------- ---------- ---------- ----------
Income before income taxes................ 17,099 14,308 10,256 (17,901) 23,762
Income taxes.............................. (222) (6,135) (1,964) (8,321)
------- ---------- ---------- ---------- ----------
Net income................................ $16,877 $ 8,173 $ 8,292 $ (17,901) $ 15,441
======= ========== ========== ========== ==========

ISP CHEMCO INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) - (CONTINUED)

NOTE 11. GUARANTOR FINANCIAL INFORMATION - (CONTINUED)

ISP CHEMCO INC.
CONDENSED CONSOLIDATING STATEMENT OF OPERATIONS
NINE MONTHS ENDED OCTOBER 2, 2005
(THOUSANDS)

Non-
Parent Guarantor Guarantor
Company Subsidiaries Subsidiaries Eliminations Consolidated
------- ------------ ------------ ------------ ------------

Net sales ................................ $ - $ 406,009 $ 460,220 $ - $ 866,229
Intercompany net sales ................... - 203,592 13,273 (216,865) -
------- ---------- ---------- ---------- ----------
Total net sales ....................... - 609,601 473,493 (216,865) 866,229
------- ---------- ---------- ---------- ----------
Cost of products sold .................... - (474,745) (315,372) 216,865 (573,252)
Selling, general and administrative ...... - (87,487) (61,883) (149,370)
Other operating charges................... - (12,195) (2,200) (14,395)
Amortization of intangible assets......... - (1,021) - (1,021)
------- ---------- ---------- ---------- ----------

Operating income ......................... - 34,153 94,038 - 128,191
Equity in income of subsidiaries.......... 52,742 - - (52,742) -
Intercompany royalty income (expense)..... - 42,495 (42,495) -
Intercompany dividend income ............. - 5,368 - (5,368) -
Interest expense ......................... 2,850 (46,396) 684 (42,862)
Interest income .......................... - 137 1,546 1,683
Other expense, net ....................... (3) (5,929) (6,479) (12,411)
------- ---------- ---------- ---------- ----------
Income before income taxes ............... 55,589 29,828 47,294 (58,110) 74,601
Income taxes ............................. (996) (10,803) (13,577) (25,376)
------- ---------- ---------- ---------- ----------
Net income ............................... $54,593 $ 19,025 $ 33,717 $ (58,110) $ 49,225
======= ========== ========== ========== ==========

ISP CHEMCO INC.
CONDENSED CONSOLIDATING STATEMENT OF OPERATIONS
NINE MONTHS ENDED OCTOBER 3, 2004
(THOUSANDS)

Non-
Parent Guarantor Guarantor
Company Subsidiaries Subsidiaries Eliminations Consolidated
------- ------------ ------------ ------------ ------------

Net sales................................. $ - $ 366,444 $ 414,894 $ - $ 781,338
Intercompany net sales.................... - 183,833 12,981 (196,814) -
------- ---------- ---------- ---------- ----------
Total net sales........................ - 550,277 427,875 (196,814) 781,338
------- ---------- ---------- ---------- ----------
Cost of products sold..................... - (404,391) (294,693) 196,814 (502,270)
Selling, general and administrative....... - (90,989) (55,732) (146,721)
Amortization of intangible assets......... - (775) - (775)
------- ---------- ---------- ---------- ----------

Operating income.......................... - 54,122 77,450 - 131,572
Equity in income of subsidiaries.......... 59,897 - - (59,897) -
Intercompany royalty income (expense)..... - 31,357 (31,357) -
Intercompany dividend income.............. - 4,611 - (4,611) -
Interest expense.......................... 2,056 (43,199) 251 (40 892)
Interest income .......................... - 41 1,454 1,495
Other expense, net........................ (5) (2,984) (2,354) (5,343)
------- ---------- ---------- ---------- ----------
Income before income taxes................ 61,948 43,948 45,444 (64,508) 86,832
Income taxes.............................. (718) (21,351) (8,144) (30,213)
------- ---------- ---------- ---------- ----------
Net income................................ $61,230 $ 22,597 $ 37,300 $ (64,508) $ 56,619
======= ========== ========== ========== ==========

ISP CHEMCO INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) - (CONTINUED)

NOTE 11. GUARANTOR FINANCIAL INFORMATION - (CONTINUED)

ISP CHEMCO INC.
CONDENSED CONSOLIDATING BALANCE SHEET
OCTOBER 2, 2005
(THOUSANDS)

Non-
Parent Guarantor Guarantor
Company Subsidiaries Subsidiaries Eliminations Consolidated
--------- ------------ ------------ ------------ ------------

ASSETS
Current Assets:
Cash and cash equivalents ............. $ 4 $ 3,712 $ 15,840 $ - $ 19,556
Accounts receivable, trade, net ....... - 9,958 126,261 136,219
Accounts receivable, other ............ - 3,342 32,656 35,998
Receivables from related parties....... - 16,180 - 16,180
Inventories ........................... - 146,082 93,423 239,505
Deferred income tax assets............. - 29,351 - 29,351
Prepaid expenses ...................... - 5,194 2,365 7,559
--------- ---------- --------- ---------- -----------
Total current assets ................ 4 213,819 270,545 - 484,368
Investment in subsidiaries ............... 331,974 218,363 - (550,337) -
Intercompany loans ....................... 22,060 (14,485) (7,575) -
Due from (to) subsidiaries, net .......... - 86,652 (86,652) -
Property, plant and equipment, net ....... - 534,751 86,947 621,698
Goodwill, net ............................ 89,931 240,928 9,161 340,020
Intangible assets, net.................... - 18,546 - 18,546
Long-term receivable from related party .. - - 35,575 35,575
Other assets ............................. - 77,949 1,175 79,124
--------- ---------- --------- ---------- -----------
Total Assets ............................. $ 443,969 $1,376,523 $ 309,176 $ (550,337) $ 1,579,331
========= ========== ========= ========== ===========

LIABILITIES AND SHAREHOLDER'S EQUITY
Current Liabilities:
Short-term debt ....................... $ - $ - $ 71 $ - $ 71
Current maturities of long-term debt .. - 2,707 141 2,848
Accounts payable ...................... - 47,041 39,069 86,110
Accrued liabilities ................... - 63,246 23,050 86,296
Income taxes payable................... - 48,130 7,223 55,353
--------- ---------- --------- ---------- -----------
Total Current liabilities ........... - 161,124 69,554 - 230,678
Long-term debt less current maturities ... - 685,587 281 685,868
Deferred income tax liabilities........... - 116,782 13,941 130,723
Other liabilities ........................ - 81,056 7,037 88,093
Total Shareholder's Equity ............... 443,969 331,974 218,363 (550,337) 443,969
--------- ---------- --------- ---------- -----------
Total Liabilities and Shareholder's
Equity ................................ $ 443,969 $1,376,523 $ 309,176 $ (550,337) $ 1,579,331
========= ========== ========= ========== ===========

ISP CHEMCO INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) - (CONTINUED)

NOTE 11. GUARANTOR FINANCIAL INFORMATION - (CONTINUED)

ISP CHEMCO INC.
CONDENSED CONSOLIDATING BALANCE SHEET
DECEMBER 31, 2004
(THOUSANDS)

Non-
Parent Guarantor Guarantor
Company Subsidiaries Subsidiaries Eliminations Consolidated
--------- ------------ ------------ ------------ ------------

ASSETS
Current Assets:
Cash and cash equivalents ............. $ 1 $ 14,659 $ 18,279 $ - $ 32,939
Accounts receivable, trade, net ....... - 4,870 100,867 105,737
Accounts receivable, other ............ - 2,155 19,309 21,464
Receivables from related parties....... (38) 15,224 - 15,186
Inventories ........................... - 108,810 82,925 191,735
Deferred income tax assets............. - 14,833 - 14,833
Prepaid expenses ...................... - 4,782 2,191 6,973
--------- ---------- --------- ----------- -----------
Total current assets ................ (37) 165,333 223,571 - 388,867
Investment in subsidiaries ............... 310,959 226,870 - (537,829) -
Intercompany loans ....................... 21,337 (12,848) (8,489) -
Due from (to) subsidiaries, net .......... - 46,539 (46,539) -
Property, plant and equipment, net ....... - 500,700 98,385 599,085
Goodwill, net ............................ 89,931 240,928 6,935 337,794
Intangible assets, net ................... - 18,677 - 18,677
Long-term receivable from related party .. - - 34,043 34,043
Other assets ............................. - 63,920 530 64,450
--------- ---------- --------- ---------- -----------
Total Assets ............................. $ 422,190 $1,250,119 $ 308,436 $ (537,829) $ 1,442,916
========= ========== ========= ========== ===========

LIABILITIES AND SHAREHOLDER'S EQUITY
Current Liabilities:
Short-term debt ....................... $ - $ - $ 71 $ - $ 71
Current maturities of long-term debt .. - 2,766 166 2,932
Accounts payable ...................... - 45,554 20,245 65,799
Accrued liabilities ................... - 52,737 31,812 84,549
Income taxes payable................... 50,260 - 6,224 56,484
-------- ---------- --------- ---------- -----------
Total Current liabilities ........... 50,260 101,057 58,518 - 209,835
Long-term debt less current maturities ... - 648,940 428 649,368
Deferred income tax liabilities........... - 106,852 15,970 122,822
Other liabilities ........................ - 82,311 6,650 88,961
Total Shareholder's Equity ............... 371,930 310,959 226,870 (537,829) 371,930
-------- ---------- --------- ---------- -----------
Total Liabilities and Shareholder's
Equity ................................ $ 422,190 $1,250,119 $ 308,436 $ (537,829) $ 1,442,916
========= ========== ========= ========== ===========

ISP CHEMCO INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) - (CONTINUED)

NOTE 11. GUARANTOR FINANCIAL INFORMATION - (CONTINUED)

ISP CHEMCO INC.
CONDENSED CONSOLIDATING STATEMENT OF CASH FLOW
NINE MONTHS ENDED OCTOBER 2, 2005
(THOUSANDS)

Non-
Parent Guarantor Guarantor
Company Subsidiaries Subsidiaries Consolidated
---------- ------------ ------------ ------------

Cash flows from operating activities:
Net income (loss)....................................... $ (3,517) $ 19,025 $ 33,717 $ 49,225
Adjustments to reconcile net income (loss) to net cash
provided by (used in) operating activities:
Impairment of fixed assets........................... - 10,532 - 10,532
Depreciation......................................... - 41,710 10,439 52,149
Amortization of intangible assets.................... - 1,021 - 1,021
Noncash interest charges............................. - 1,510 - 1,510
Deferred income taxes................................ - (4,588) (2,029) (6,617)
Increase in working capital items....................... - (22,532) (42,692) (65,224)
Proceeds from sale of accounts receivable............... - - 2,820 2,820
Increase in receivables from related parties............ (38) (956) (1,532) (2,526)
Change in amounts due to (from) subsidiaries............ - (41,002) 41,002 -
Change in investment in and advances to affiliates...... (28,719) 55,389 (26,670) -
Other, net.............................................. - 1,151 (223) 928
--------- ---------- ----------- ---------
Net cash provided by (used in) operating activities....... (32,274) 61,260 14,832 43,818
--------- ---------- ----------- ---------
Cash flows from investing activities:
Capital expenditures and acquisition.................... - (115,605) (9,513) (125,118)
--------- ---------- ----------- ---------
Net cash used in investing activities..................... - (115,605) (9,513) (125,118)
--------- ---------- ----------- ---------
Cash flows from financing activities:
Proceeds from borrowings under revolving
credit facilities..................................... - 215,800 - 215,800
Repayments of borrowings under revolving
credit facilities..................................... - (177,800) - (177,800)
Repayments of long-term debt............................ - (1,607) (135) (1,742)
Change in net intercompany loans........................ (723) 1,637 (914) -
Intercompany dividends.................................. - 5,368 (5,368) -
Dividends to parent company............................. (107,000) - - (107,000)
Capital contribution from parent company................ 140,000 - - 140,000
--------- ---------- ----------- ---------
Net cash provided by (used in) financing activities....... 32,277 43,398 (6,417) 69,258
--------- ---------- ----------- ---------
Effect of exchange rate fluctuations on cash and cash
equivalents............................................. - - (1,341) (1,341)
--------- ---------- ----------- ---------
Net change in cash and cash equivalents................... 3 (10,947) (2,439) (13,383)
Cash and cash equivalents, beginning of period............ 1 14,659 18,279 32,939
--------- ---------- ----------- ---------
Cash and cash equivalents, end of period.................. $ 4 $ 3,712 $ 15,840 $ 19,556
======== ========== =========== =========

ISP CHEMCO INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) - (CONTINUED)

NOTE 11. GUARANTOR FINANCIAL INFORMATION - (CONTINUED)

ISP CHEMCO INC.
CONDENSED CONSOLIDATING STATEMENT OF CASH FLOW
NINE MONTHS ENDED OCTOBER 3, 2004
(THOUSANDS)

Non-
Parent Guarantor Guarantor
Company Subsidiaries Subsidiaries Consolidated
--------- ------------ ------------ ------------

Cash provided by (used in) operating activities:
Net income.............................................. $ (3,278) $ 22,597 $ 37,300 $ 56,619
Adjustments to reconcile net income to net cash
provided by (used in) operating activities:
Depreciation......................................... - 37,533 10,411 47,944
Amortization of intangible assets.................... - 775 - 775
Noncash interest charges............................. - 1,604 - 1,604
Deferred income taxes................................ - 19,069 1,402 20,471
Increase in working capital items....................... (5,096) (22,457) (12,919) (40,472)
Proceeds from sale of accounts receivable............... - - 3,930 3,930
Increase in receivables from related parties............ 1 (3,287) (1,915) (5,201)
Change in amounts due to (from) subsidiaries............ - 25,736 (25,736) -
Change in investment in and advances to affiliates...... 9,246 (2,776) (6,470) -
Other, net.............................................. (875) 2,032 (212) 945
--------- ---------- ----------- ---------
Net cash provided by (used in) operating activities....... (2) 80,826 5,791 86,615
--------- ---------- ----------- ---------
Cash used in investing activities:
Capital expenditures and acquisitions................... - (54,920) (20,020) (74,940)
--------- ---------- ----------- ---------
Net cash used in investing activities..................... - (54,920) (20,020) (74,940)
--------- ---------- ----------- ---------
Cash provided by (used in) financing activities:
Decrease in short-term debt............................. - - (1) (1)
Proceeds from issuance of debt.......................... - 31,188 - 31,188
Proceeds from borrowings under revolving
credit facilities..................................... - 126,150 - 126,150
Repayments of borrowings under revolving
credit facilities..................................... - (126,150) - (126,150)
Repayments of long-term debt............................ - (2,160) (69) (2,229)
Loan from related party................................. - - 15,000 15,000
Increase in loan to related party....................... - (7,760) - (7,760)
(Increase) decrease in intercompany loans............... - (506) 506 -
Debt issuance costs..................................... - (1,725) - (1,725)
Intercompany dividends.................................. 67,163 (62,552) (4,611) -
Dividend to parent company.............................. (67,163) - - (67,163)
--------- ---------- ----------- ---------
Net cash provided by (used in) financing activities....... - (43,515) 10,825 (32,690)
--------- ---------- ----------- ---------
Effect of exchange rate fluctuations on cash and cash
equivalents............................................. - - (165) (165)
--------- ---------- ----------- ---------
Net change in cash and cash equivalents................... (2) (17,609) (3,569) (21,180)
Cash and cash equivalents, beginning of period............ 5 29,009 27,412 56,426
--------- ---------- ----------- ---------
Cash and cash equivalents, end of period.................. $ 3 $ 11,400 $ 23,843 $ 35,246
========= ========== =========== =========

ISP CHEMCO INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) - (CONTINUED)

NOTE 12. CONTINGENCIES

For information regarding contingencies, reference is made to Note 21 to
consolidated financial statements contained in the 2004 Form 10-K.

Environmental Litigation

The Company, together with other companies, is a party to a variety of
proceedings and lawsuits involving environmental matters ("Environmental
Claims") under the Comprehensive Environmental Response Compensation and
Liability Act, Resource Conservation and Recovery Act and similar state laws, in
which recovery is sought for the cost of cleanup of contaminated sites or in
which remedial obligations are imposed. A number of these Environmental Claims
are in the early stages or have been dormant for protracted periods.

While the Company cannot predict whether adverse decisions or events can
occur in the future, in the opinion of the Company's management, the resolution
of the Environmental Claims should not be material to the business, liquidity,
results of operations, cash flows or financial position of the Company. The
Company accrues environmental costs when it is probable that it has incurred a
liability and the expected amount can be reasonably estimated. The amount
accrued reflects the Company's assumptions about remedial requirements at the
contaminated site, the nature of the remedy, the outcome of discussions with
regulatory agencies and other potential responsible parties at multiple-party
sites, and the number and financial viability of other potentially responsible
parties. Adverse decisions or events, particularly as to increases in remedial
costs, discovery of new contamination, assertion of natural resource damages,
plans for development of the Company's Linden, New Jersey property, and the
liability and the financial responsibility of the Company's insurers and of the
other parties involved at each site and their insurers, could cause the Company
to increase its estimate of liability or decrease its estimate of insurance
recoveries in respect of those matters. It is not currently possible to estimate
the amount or range of any additional liability.

The Company recognizes receivables for estimated environmental insurance
recoveries that relate to both past expenses and estimated future liabilities
when the claim for recovery is deemed probable. After considering the relevant
legal issues and other pertinent factors, the Company believes that it will
receive the estimated insurance recoveries and that the insurance recoveries
could be in excess of the current estimated liability for all environmental
claims, although there can be no assurance in this regard. Significant judgment
is involved in estimating environmental liabilities and related insurance
recoveries.

The estimated liability for certain contaminated sites represents the
present value of long-term future post-closure costs. Estimated future payments
are discounted where ongoing operating and maintenance expenses are predicted to
run over a multi-year period and the amount and timing can be reliably
determined. These estimated costs are discounted at a rate of 5%, which
represents a risk-free interest rate on monetary assets with maturities
comparable to the environmental liability.

ISP CHEMCO INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) - (CONTINUED)

NOTE 12. CONTINGENCIES - (CONTINUED)

Tax Claim Against G-I Holdings Inc.

The predecessor of ISP and certain of its domestic subsidiaries were
parties to tax sharing agreements with members of a consolidated group for
federal income tax purposes that included G-I Holdings Inc. (the "G-I Holdings
Group") in certain prior years. Until January 1, 1997, ISP and its domestic
subsidiaries were included in the consolidated federal income tax returns of the
G-I Holdings Group and, accordingly, would be severally liable for any tax
liability of the G-I Holdings Group in respect of those prior years. Those tax
sharing agreements are no longer applicable with respect to the tax liabilities
of ISP for periods subsequent to January 1, 1997, because neither the Company
nor any of its domestic subsidiaries have been members of the G-I Holdings Group
for periods after January 1, 1997. In January 2001, G-I Holdings filed a
voluntary petition for reorganization under Chapter 11 of the U.S. Bankruptcy
Code due to its asbestos-related bodily injury claims relating to the inhalation
of asbestos fiber.

On September 15, 1997, G-I Holdings received a notice from the Internal
Revenue Service ("IRS") of a deficiency in the amount of $84.4 million (after
taking into account the use of net operating losses and foreign tax credits
otherwise available for use in later years) in connection with the formation in
1990 of Rhone-Poulenc Surfactants and Specialties, L.P. (the "Surfactants
Partnership"), a partnership in which G-I Holdings held an interest. On
September 21, 2001, the IRS filed a proof of claim with respect to such
deficiency in the G-I Holdings bankruptcy against G-I Holdings and ACI Inc., a
subsidiary of G-I Holdings which also held an interest in the Surfactants
Partnership and also has filed a voluntary petition for reorganization under
Chapter 11 of the U.S. Bankruptcy Code. The basis for the proof of claim is
whether the formation of the Surfactants Partnership qualified as a tax-free
contribution pursuant to Section 721 of the Internal Revenue Code. If the proof
of claim is sustained, ISP and/or certain of its subsidiaries together with G-I
Holdings and several current and former subsidiaries of G-I Holdings would be
severally liable for taxes and interest in the amount of approximately $305
million, computed as of October 2, 2005. On May 7, 2002, G-I Holdings, together
with ACI Inc., filed an objection to the proof of claim, which objection will be
heard by the United States District Court for the District of New Jersey
overseeing the G-I Holdings bankruptcy. G-I Holdings has advised the Company
that it believes that it will prevail in this tax matter involving the
Surfactants Partnership, although there can be no assurance in this regard. The
Company believes that the ultimate disposition of this matter will not have a
material adverse effect on its business, financial position or results of
operations. For additional information relating to G-I Holdings, reference is
made to Notes 7 and 21 to consolidated financial statements contained in the
2004 Form 10-K.

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL
CONDITION AND RESULTS OF OPERATIONS

Unless otherwise indicated by the context, "we," "us" and "our" refer to
ISP Chemco Inc. and its consolidated subsidiaries.

CRITICAL ACCOUNTING POLICIES

There have been no significant changes in our critical accounting
policies during the first nine months of 2005. In order to supplement and
enhance the disclosures on critical accounting policies contained in the
"Management's Discussion and Analysis of Financial Condition and Results of
Operations" included in our Annual Report on Form 10-K for the fiscal year ended
December 31, 2004 filed with the Securities and Exchange Commission on March 31,
2005, our critical accounting policies, with appropriate modifications, are set
forth in full below.

Revenue Recognition

Our revenue recognition policy is in accordance with U.S. generally
accepted accounting principles, which require the recognition of sales when
there is evidence of a sales agreement, the delivery of goods has occurred, the
sales price is fixed or determinable and the collectibility of revenue is
reasonably assured. Normal terms for sales of specialty and industrial chemicals
are 30 days net. Normal terms for sales of mineral products include a 1%
discount if payment is made not later than the 15th of the month following date
of sale. There are no special conditions for sales to third party distributors.
For revenues associated with technology licensing activities, revenue is
recognized using the proportional performance method based on the amount of
labor effort completed relative to the total estimated labor effort required,
which we believe is most representative of the earnings process.

Allowance for Doubtful Accounts

We maintain allowances for doubtful accounts for estimated losses
resulting from the inability of our customers to make required payments.
Management continuously assesses the financial condition of our customers and
the markets in which these customers participate and adjusts credit limits or
the allowance for doubtful accounts based on this periodic review. If the
financial condition of our customers were to deteriorate, resulting in an
impairment of their ability to make payments, our ability to collect on accounts
could be negatively impacted, in which case additional allowances may be
required.

Inventories

Inventories are valued at the lower of cost or market. The LIFO
(last-in, first-out) method is utilized to determine cost for substantially all
domestic acetylene-based finished goods and work-in-process and the raw
materials to produce these products. All other inventories are valued on the
FIFO (first-in, first out) method. We write down our inventories for estimated
obsolescence or unmarketable inventories equal to the difference between the
cost of inventories and their estimated market value based upon assumptions

about future demand and market conditions. If actual market conditions are less
favorable than those projected by management, additional inventory write-downs
may be required.

Goodwill and Other Intangible Assets

Goodwill represents the excess of the purchase price of an acquired
enterprise or assets over the fair value of the identifiable assets acquired and
liabilities assumed. Through December 31, 2001, we amortized goodwill and
certain other intangible assets on a straight-line basis over the expected
useful lives of the underlying assets. In accordance with the provisions of
Statement of Financial Accounting Standards, which we refer to as "SFAS," No.
142, "Goodwill and Other Intangible Assets," effective January 1, 2002, goodwill
is no longer being amortized over its estimated useful life. However, as
required by SFAS No. 142, tests for impairment of goodwill are performed on at
least an annual basis, or at any other time if events occur or circumstances
indicate that the carrying amount of goodwill may not be recoverable. The
impairment testing is performed in two steps: (i) we determine impairment by
comparing the fair value of a reporting unit with its carrying value; and (ii)
if there is an impairment, we measure the amount of impairment loss by comparing
the implied fair value of goodwill with the carrying amount of that goodwill.

To determine the fair value of each reporting unit, we utilize a combination
of an "income" approach and a "market value" approach. With the "income"
approach, we develop a discounted cash flow analysis based upon budgets and
projections reviewed and utilized by our management. In addition to the
projected cash flow, we develop an appropriate terminal value based on the
operating results for the last year in the projection. Second, we develop a
"market value" approach to value each reporting unit, utilizing profitability
data of comparable publicly traded firms in each industry and compare the
reporting unit with those independent firms. The two methods are then correlated
based on the relevance and reliability of the two approaches.

Valuation of Long-Lived Assets

Effective January 1, 2002, we adopted SFAS No. 144, "Accounting for the
Impairment or Disposal of Long-Lived Assets." At least annually, and more often
if events or circumstances warrant such a review, the Company reviews the
recoverability of long-lived assets to be held and used, including amortizable
intangible assets, and identifies and measures any potential impairments. The
carrying value of a long-lived asset to be held and used is considered impaired
when the anticipated undiscounted cash flows from such an asset are less than
the carrying value of the asset. If that occurs, a loss would be recognized
based on the amount by which the carrying value exceeds the fair value of the
long-lived asset.

Income Taxes

The objective of accounting for income taxes is to recognize the amount of
taxes payable or refundable for the current year and deferred tax

liabilities and assets for the future tax consequences of events that have been
recognized in our financial statements or tax returns. We account for our income
taxes under the asset and liability method. Deferred tax assets and liabilities
are recognized for the future tax consequences attributable to differences
between the financial statement carrying amounts of existing assets and
liabilities and their respective tax bases and operating loss and tax credit
carryforwards. Deferred tax assets and liabilities are measured using enacted
tax rates that are expected to apply to taxable income in the years in which
those temporary differences are expected to be recovered or settled. The effect
on deferred tax assets and liabilities of a change in tax rates is recognized in
income in the period that includes the enactment date.

In the determination of our current year tax provision, we assume that all
foreign earnings are remitted to the United States, net of applicable foreign
tax credits, and since upon remittance such earnings are taxable, we provide
federal income taxes on income from our foreign subsidiaries. Since significant
judgment is required to assess the future tax consequences of events that have
been recognized in our financial statements or tax returns, we consider such
estimates to be critical to the preparation of our financial statements.

We believe that our current assumptions and other considerations used to
estimate the current year effective rate and deferred tax positions are
appropriate. However, if the actual outcome of future tax consequences differs
from our estimates and assumptions, the resulting change to the provision for
income taxes could have a material adverse impact on our consolidated financial
statements.

Environmental Liability

We accrue environmental costs when it is probable that we have incurred
a liability and the expected amount can be reasonably estimated. The amount
accrued reflects our assumptions about remedial requirements at the contaminated
site, the nature of the remedy, the outcome of discussions with regulatory
agencies and other potential responsible parties at multiple-party sites, and
the number and financial viability of other potentially responsible parties.
Adverse decisions or events, particularly as to increases in remedial costs,
discovery of new contamination, assertion of natural resource damages, plans for
development of our Linden, New Jersey property, and the liability and the
financial responsibility of our insurers and of the other parties involved at
each site and their insurers, could cause us to increase our estimate of
liability or decrease our estimate of insurance recoveries in respect of those
matters. It is not currently possible to estimate the amount or range of any
additional liability.

We recognize receivables for estimated environmental insurance recoveries
that relate to both past expenses and estimated future liabilities when the
claim for recovery is deemed probable. After considering the relevant legal
issues and other pertinent factors, we believe that we will receive the
estimated insurance recoveries and that the insurance recoveries could be in
excess of the current estimated liability for all environmental claims, although
there can be no assurance in this regard. Significant judgment is involved in
estimating environmental liabilities and related insurance recoveries.

predicted to run over a multi-year period and the amount and timing can be
reliably determined. These estimated costs are discounted at a rate of 5%, which
represents a risk-free interest rate on monetary assets with maturities
comparable to the environmental liability.

Pension and Other Postemployment Benefits

We maintain defined benefit plans that provide eligible employees with
retirement benefits. In addition, while we generally do not provide
postretirement medical and life insurance benefits, we subsidize such benefits
for certain employees and certain retirees. The costs and obligations related to
these benefits reflect our assumptions related to general economic conditions
(particularly interest rates), expected return on plan assets, and rate of
compensation increases for employees. We set the discount rate assumption
annually for our retirement-related benefit plans at the measurement dates to
reflect the yield of high-quality fixed-income debt instruments. The expected
long-term rate of return on assets is derived from a detailed periodic study
conducted by our actuaries and our financial management. The study includes a
review of anticipated future long-term performance of individual asset
categories. While the study gives appropriate consideration to recent plan
performance and historical returns, the assumption is primarily a long-term
prospective rate. The expected long-term rate of return assumption for our
domestic hourly retirement plan is 9.5%. A 25 basis points increase or decrease
in the discount rate would result in a plus or minus $0.1 million annual impact
on pension expense and a plus or minus $0.9 million impact on the projected
benefit obligation. A 25 basis points increase or decrease in the expected
long-term rate of return on assets would result in a plus or minus $0.1 million
annual impact on pension expense.

Projected health care benefits additionally reflect our assumptions about
health care cost trends. The cost of providing plan benefits also depends on
demographic assumptions including retirements, mortality, turnover, and plan
participation. If actual experience differs from these assumptions, the cost of
providing these benefits could increase or decrease.

RESULTS OF OPERATIONS - THIRD QUARTER 2005 COMPARED WITH
THIRD QUARTER 2004

Overview

We recorded net income of $13.0 million for the third quarter of 2005,
which included pre-tax other operating charges totaling $3.9 million, compared
with net income of $15.4 million in the third quarter of 2004. The lower results
for the third quarter of 2005 were mainly attributable to higher interest
expense and higher other expense, net, due to unfavorable foreign exchange, and
lower operating income, which included the $3.9 million of other operating
charges.

Net Sales. Net sales by business segment for the third quarter of 2005
and 2004 were:

Third Quarter Ended
---------------------------
October 2, October 3,
2005 2004
---------- ----------
(Millions)
Specialty chemicals.................... $ 179.1 $ 168.7
Industrial chemicals................... 75.2 50.5
Mineral products....................... 40.1 33.6
--------- ---------
Net sales............................ $ 294.4 $ 252.8
========= =========

Net sales for the third quarter of 2005 were $294.4 million compared
with $252.8 million in the third quarter of 2004. The $41.6 million (16%)
increase in sales resulted primarily from higher unit volumes in all business
segments and, to a lesser extent, higher pricing in all business segments, and
included revenues associated with technology licensing activities.

Gross Margin. Our gross margin in the third quarter of 2005 was 30.6%
compared with 34.1% in the third quarter of 2004. The lower margin was
attributable to higher raw material and energy costs in all business segments,
partially offset by favorable pricing.

Selling, General and Administrative. Selling, general and administrative
expenses increased 2% in the third quarter of 2005 to $49.0 million from $48.0
million in the third quarter of 2004; however, as a percent of sales, these
expenses decreased to 16.6% in the third quarter of 2005 from 19.0% in the third
quarter of 2004. The increase in selling, general and administrative expenses in
the third quarter of 2005 related primarily to higher freight and distribution
costs and increased selling expenses as a result of the higher sales levels.

Other Operating Charges. Other operating charges of $3.9 million in the
third quarter of 2005 represent charges related to our program for the
restructuring and consolidation of production capacity in the food ingredients
product line within the specialty chemicals business segment. In the fourth
quarter of 2004, we decided to transfer certain production assets in the food
ingredients product line from a leased facility in England to our plant in
Girvan, Scotland and accrued $0.5 million for related severance costs. We
announced in June 2005 that we would be closing our San Diego, California
alginates plant in 2006 and transferring the manufacturing of many of the San
Diego-produced alginates products to the Girvan plant. In the third quarter of
2005, we recognized charges of $3.9 million related to the closings for the San
Diego plant and the leased facility in England. These charges included $1.8
million related to lease terminations, $1.2 million for severance costs and $0.9
million for other site exit costs. Additional expenses expected to be recognized
related to these costs is in a range of $2.0 million to $4.0 million.

Operating Income. Operating income (loss) by business segment for the
third quarter of 2005 and 2004 was:

Third Quarter Ended
---------------------------
October 2, October 3,
2005 2004
---------- ----------
(Millions)
Specialty chemicals.................... $ 24.0 $ 33.8
Industrial chemicals................... 8.4 (0.7)
Mineral products....................... 4.7 5.5
--------- ---------
Total segment operating income....... 37.1 38.6
Unallocated corporate office........... (0.2) (0.8)
--------- ---------
Operating income..................... $ 36.9 $ 37.8
========= =========

Operating income for the third quarter of 2005 was $36.9 million, which
included the $3.9 million of other operating charges discussed above. Excluding
such charges, operating income increased by 8% to $40.8 million compared with
$37.8 million in the third quarter of 2004 (see "Non-GAAP Financial Measures"
below). Operating income for the 2005 third quarter was favorably impacted by
higher unit volumes and pricing, offset by increased raw material and energy
costs, and higher manufacturing costs including depreciation expense associated
with capacity expansion programs.

The specialty chemicals segment recorded operating income of $24.0 million
for the third quarter of 2005. On a comparable basis, excluding the
aforementioned other operating charges of $3.9 million, operating income for the
segment was $27.9 million compared with $33.8 million in the third quarter of
2004. The lower operating income was primarily due to higher raw material,
energy and manufacturing costs.

The industrial chemicals segment recorded operating income of $8.4 million
in the third quarter of 2005 compared with an operating loss of $0.7 million in
the third quarter of 2004. The segment's improved performance was achieved
primarily as a result of higher unit volumes (including the acquisition of the
Lima, Ohio production facility in the first quarter of 2005) and favorable
pricing, partially offset by increased raw material and energy costs.

Operating income for the mineral products segment was $4.7 million in the
third quarter of 2005 compared with $5.5 million in the third quarter of 2004,
as the favorable impact of higher unit volumes and pricing was more than offset
by increased raw material and energy costs and higher freight and distribution
expenses.

Interest Expense. Interest expense for the third quarter of 2005 was
$14.9 million compared with $13.3 million in the same period in 2004. The $1.6
million (12%) higher interest expense was attributable to higher average
interest rates ($1.5 million impact) and higher average borrowings ($0.1 million
impact).

Other Expense, Net. Other expense, net, comprises foreign exchange gains
and losses resulting from the revaluation of foreign currency-denominated
accounts receivable and payable as a result of changes in exchange rates, and
other nonoperating items of expense. Other expense, net, was $2.8 million in the
third quarter of 2005 compared with $1.2 million in the third quarter of 2004.
The higher expense in the third quarter of 2005 was due to unfavorable foreign
exchange.

Income Taxes. In the third quarter of 2005, we recorded a provision for
income taxes of $6.8 million. Our effective tax rate was 34.4% for the third
quarter of 2005 and 35.0% for the third quarter of 2004.

Business Segment Review

A discussion of operating results for each of our business segments
follows. We operate our business through three reportable business segments:
specialty chemicals, industrial chemicals and mineral products. The operating
income for the third quarter of 2005 for the specialty chemicals business
segment discussed below is adjusted for the non-GAAP financial measures in the
table below.

Non-GAAP Financial Measures

The business segment review below and the discussion of operating
income above contain information regarding non-GAAP financial measures contained
within the meaning of Item 10 of Regulation S-K promulgated by the Securities
and Exchange Commission. As used herein, "GAAP" refers to U.S. generally
accepted accounting principles. We use non-GAAP financial measures to eliminate
the effect of certain other operating gains and charges on reported operating
income. Management believes that these financial measures are useful to
bondholders and financial institutions because such measures exclude
transactions that are unusual due to their nature or infrequency and therefore
allow bondholders and financial institutions to more readily compare our
company's performance from period to period. Management uses this information in
monitoring and evaluating our company's performance and the performance of
individual business segments. The non-GAAP financial measures included herein
have been reconciled to the most directly comparable GAAP financial measure as
is required under Item 10 of Regulation S-K regarding the use of such financial
measures. These non-GAAP financial measures should be considered in addition to,
and not as a substitute, or superior to, operating income or other measures of
financial performance determined in accordance with GAAP.

Third Quarter Ended
---------------------
October 2, October 3,
2005 2004
--------- ---------
(Millions)
Reconciliation of non-GAAP financial measures:

Operating income per GAAP............................... $ 36.9 $ 37.8
Non-GAAP adjustments:
Add: Other operating charges(1).................... 3.9 -
--------- ---------
Operating income as adjusted............................ $ 40.8 $ 37.8
========= =========
Supplemental Business Segment Information:

Operating income (loss):
Operating Income per GAAP - Specialty Chemicals.... $ 24.0 $ 33.8
Non-GAAP adjustments (1)........................... 3.9 -
--------- ---------
Operating Income - Specialty Chemicals as adjusted. $ 27.9 $ 33.8
========= =========

Operating Income (Loss) per GAAP - Industrial
Chemicals........................................ $ 8.4 $ (0.7)
Non-GAAP adjustments............................... - -
--------- ---------
Operating Income (Loss) - Industrial Chemicals as
adjusted......................................... $ 8.4 $ (0.7)
========= =========

Operating Income per GAAP - Mineral Products....... $ 4.7 $ 5.5
Non-GAAP adjustments............................... - -
--------- ---------
Operating Income - Mineral Products as adjusted.... $ 4.7 $ 5.5
========= =========

Total segment operating income as adjusted......... $ 41.0 $ 38.6
Unallocated corporate office items per GAAP........ (0.2) (0.8)
--------- ---------
Operating income as adjusted....................... $ 40.8 $ 37.8
========= =========

(1) Non-GAAP adjustments in the third quarter of 2005 of $3.9 million
represent severance and other costs related to a program for the
restructuring and consolidation of production capacity in the food
ingredients product line within the specialty chemicals segment. See
"Other Operating Charges" above.

Specialty Chemicals

Sales in the third quarter of 2005 were $179.1 million compared with $168.7
million in the same period in 2004. The 6% increase in sales was principally due
to higher unit volumes of pharmaceutical and beverage products.

Operating income for the specialty chemicals segment was $24.0 million for
the third quarter of 2005. On a comparable basis, excluding the aforementioned
other operating charges, operating income for the segment was $27.9 million
compared with $33.8 million in the third quarter of 2004. The lower operating
income was primarily attributable to higher raw material and energy costs
(totaling $9.4 million).

Industrial Chemicals

Sales in the third quarter of 2005 were $75.2 million compared with
$50.5 million in the third quarter of 2004. The 49% increase in sales resulted
primarily from higher unit volumes ($17.4 million), including the impact of the
first quarter 2005 acquisition of the Lima, Ohio production facility and, to a
lesser extent, favorable pricing ($7.3 million).

The industrial chemicals segment recorded operating income of $8.4 million
in the third quarter of 2005 compared with an operating loss of $0.7

million in the third quarter of 2004. The segment's improved performance was
achieved mainly as a result of the higher unit volumes (including the
acquisition of the Lima, Ohio production facility). The improvement in pricing
for the industrial chemicals segment more than offset raw material and energy
cost increases (totaling $3.0 million).

Mineral Products

Sales for the mineral products segment for the third quarter of 2005
were $40.1 million compared with $33.6 million for the third quarter of 2004.
The 19% increase in sales was due to higher unit volumes ($4.2 million), as a
result of industry-wide growth, and favorable pricing. The increase in sales
included 12% higher sales to Building Materials Corporation of America, an
affiliate that we refer to as "BMCA."

Operating income for the mineral products segment was $4.7 million in the
third quarter of 2005 compared with $5.5 million for the third quarter of 2004.
The lower operating income resulted from increased raw material and energy costs
(totaling $3.9 million) and higher freight and distribution expenses, partially
offset by favorable pricing ($2.3 million) and the favorable impact of higher
unit volumes.

RESULTS OF OPERATIONS - FIRST NINE MONTHS 2005 COMPARED WITH
FIRST NINE MONTHS 2004

Overview

We recorded net income of $49.2 million for the first nine months of 2005,
which included pre-tax other operating charges totaling $14.4 million, including
a non-cash, pre-tax asset impairment charge of $10.5 million (see "Other
Operating Charges" below), compared with net income of $56.6 million in the
first nine months of 2004. The decline in net income for the first nine months
of 2005 was primarily attributable to lower operating income, which included the
$14.4 million of other operating charges, higher other expense, net, and higher
interest expense.

Net Sales. Net sales by business segment for the first nine months of
2005 and 2004 were:

Nine Months Ended
---------------------------
October 2, October 3,
2005 2004
---------- ----------
(Millions)
Specialty chemicals.................... $ 548.6 $ 533.0
Industrial chemicals................... 197.7 148.3
Mineral products....................... 119.9 100.0
--------- ---------
Net sales............................ $ 866.2 $ 781.3
========= =========

Net sales for the first nine months of 2005 were $866.2 million compared
with $781.3 million in the first nine months of 2004. The $84.9 million (11%)
increase in sales resulted primarily from higher pricing and higher unit volumes
and, to a lesser extent, the favorable impact of the weaker U.S. dollar, and
included revenues associated with technology licensing activities.

Gross Margin. Our gross margin in the first nine months of 2005 was
33.8% compared with 35.7% in the first nine months of 2004. The lower margin was
attributable to higher raw material, energy and manufacturing costs in all

business segments, partially offset by favorable pricing and the favorable
impact of the weaker U.S. dollar. Manufacturing costs in the first nine months
of 2005 were adversely impacted by plant integration costs for the Lima, Ohio
production facility acquired in the first quarter of 2005 (see further
discussion below).

Selling, General and Administrative. Selling, general and administrative
expenses increased 2% in the first nine months of 2005 to $149.4 million from
$146.7 million in the first nine months of 2004; however, as a percent of sales,
these expenses decreased to 17.3% in the first nine months of 2005 from 18.8% in
the first nine months of 2004. The increase in selling, general and
administrative expenses in the first nine months of 2005 related primarily to
higher freight and distribution costs and increased selling expenses as a result
of the higher sales levels.

Other Operating Charges. Other operating charges of $14.4 million in the
first nine months of 2005 related to our program for the restructuring and
consolidation of production capacity in the food ingredients product line within
the specialty chemicals business segment and included a $10.5 million non-cash
fixed asset impairment charge. In March 2005, we entered into a long-term supply
contract with an international company for the purchase of a product in the
specialty chemicals business that we currently manufacture at our San Diego,
California alginates plant. Accordingly, we performed an impairment review in
the first quarter of 2005 and recorded a $10.5 million non-cash fixed asset
impairment charge related to the San Diego facility. The impairment charge was
determined based on a review of anticipated future cash flows related to this
facility compared with the carrying value of the facility's fixed assets.

Other operating charges also include $3.9 million for severance costs and
closure costs related to the above restructuring and consolidation program. In
the fourth quarter of 2004, we decided to transfer certain production assets in
the food ingredients product line from a leased facility in England to our plant
in Girvan, Scotland and accrued $0.5 million for related severance costs. We
announced in June 2005 that we would be closing our San Diego, California
alginates plant in 2006 and transferring the manufacturing of many of the San
Diego-produced alginates products to the Girvan plant. In the third quarter of
2005, we recognized charges of $3.9 million related to the closings for the San
Diego plant and the leased facility in England. These charges included $1.8
million related to lease terminations, $1.2 million for severance costs and $0.9
million for other site exit costs. Additional expenses expected to be recognized
related to these costs is in a range of $2.0 million to $4.0 million.

Operating Income. Operating income (loss) by business segment for the first
nine months of 2005 and 2004 was:

Nine Months Ended
---------------------------
October 2, October 3,
2005 2004
---------- ----------
(Millions)
Specialty chemicals.................... $ 96.8 $ 121.6
Industrial chemicals................... 16.3 (2.3)
Mineral products....................... 15.7 13.6
--------- ---------
Total segment operating income....... 128.8 132.9
Unallocated corporate office items..... (0.6) (1.3)
--------- ---------
Operating income..................... $ 128.2 $ 131.6
========= =========

Operating income for the first nine months of 2005 was $128.2 million,
which included the $14.4 million of other operating charges discussed above.
Excluding such charges, operating income increased by 8% to $142.6 million from
$131.6 million in the first nine months of 2004 (see "Non-GAAP Financial
Measures" below) primarily due to favorable pricing and, to a lesser extent,
higher unit volumes, in all business segments. Increased operating income as a
result of the 11% increase in sales for the first nine months of 2005 was
partially offset by higher raw material and energy costs in all business
segments, higher manufacturing costs including depreciation expense associated
with capacity expansion programs, and $2.4 million of integration costs in
connection with the acquisition of the Lima, Ohio production facility in the
first quarter of 2005.

The specialty chemicals segment recorded operating income of $96.8 million
in the first nine months of 2005. On a comparable basis, excluding the
aforementioned impairment and other operating charges of $14.4 million,
operating income was $111.2 million compared with $121.6 million in the first
nine months of 2004. The lower operating income was primarily due to higher raw
material and energy costs.

The industrial chemicals segment recorded operating income of $16.3 million
in the first nine months of 2005 compared with an operating loss of $2.3 million
in the first nine months of 2004. The segment's improved performance was
achieved mainly as a result of higher pricing which more than offset increased
raw material and energy costs. The higher operating income was also favorably
impacted by higher unit volumes (including the acquisition of the Lima, Ohio
production facility in the first quarter of 2005), partially offset by $2.4
million of one-time integration costs in connection with that acquisition.

Operating income for the mineral products segment was $15.7 million in the
first nine months of 2005 compared with $13.6 million in the first nine months
of 2004. The 15% improvement in operating income was attributable to favorable
pricing and the positive impact of higher unit volumes, partially offset by
increased raw material and energy costs and higher freight and distribution
expenses.

Interest Expense. Interest expense for the first nine months of 2005 was
$42.9 million compared with $40.9 million in the same period in 2004. The $2.0
million (5%) higher interest expense was attributable to higher average interest
rates ($2.7 million impact), partially offset by lower average borrowings ($0.7
million impact).

Other Expense, Net. Other expense, net, comprises foreign exchange gains
and losses resulting from the revaluation of foreign currency-denominated
accounts receivable and payable as a result of changes in exchange rates, and
other nonoperating items of expense. Other expense, net, was $13.1 million in
the first nine months of 2005 compared with $6.2 million in the first nine
months of 2004. The higher expense in the first nine months of 2005 was due to
unfavorable foreign exchange.

Income Taxes. In the first nine months of 2005, we recorded a provision
for income taxes of $25.4 million. Our effective tax rate was 34.0% for the
first nine months of 2005 and 34.8% for the first nine months of 2004.

Business Segment Review

A discussion of operating results for each of our business segments
follows. We operate our business through three reportable business segments:
specialty chemicals, industrial chemicals and mineral products. The operating
income for the first nine months of 2005 for the specialty chemicals business
segment discussed below is adjusted for the non-GAAP financial measures in the
table below.

Non-GAAP Financial Measures

The business segment review below and the discussion of operating income
above contain information regarding non-GAAP financial measures contained
within the meaning of Item 10 of Regulation S-K promulgated by the Securities
and Exchange Commission. As used herein, "GAAP" refers to U.S. generally
accepted accounting principles. We use non-GAAP financial measures to eliminate
the effect of certain other operating gains and charges on reported operating
income. Management believes that these financial measures are useful to
bondholders and financial institutions because such measures exclude
transactions that are unusual due to their nature or infrequency and therefore
allow bondholders and financial institutions to more readily compare our
company's performance from period to period. Management uses this information in
monitoring and evaluating our company's performance and the performance of
individual business segments. The non-GAAP financial measures included herein
have been reconciled to the most directly comparable GAAP financial measure as
is required under Item 10 of Regulation S-K regarding the use of such financial
measures. These non-GAAP financial measures should be considered in addition to,
and not as a substitute, or superior to, operating income or other measures of
financial performance determined in accordance with GAAP.

Nine Months Ended
----------------------
October 2, October 3,
2005 2004
---------- ----------
(Millions)
Reconciliation of non-GAAP financial measures:

Operating income per GAAP............................... $ 128.2 $ 131.6
Non-GAAP adjustments:
Add: Other operating charges(1).................... 14.4 -
--------- ---------
Operating income as adjusted............................ $ 142.6 $ 131.6
========= =========

Supplemental Business Segment Information:

Operating income (loss):
Operating Income per GAAP - Specialty Chemicals.... $ 96.8 $ 121.6
Non-GAAP adjustments (1)........................... 14.4 -
--------- ---------
Operating Income - Specialty Chemicals as adjusted. $ 111.2 $ 121.6
========= =========

Operating Income (Loss) per GAAP - Industrial
Chemicals........................................ $ 16.3 $ (2.3)
Non-GAAP adjustments............................... - -
--------- ---------
Operating Income (Loss) - Industrial Chemicals as
adjusted......................................... $ 16.3 $ (2.3)
========= =========

Operating Income per GAAP - Mineral Products....... $ 15.7 $ 13.6
Non-GAAP adjustments............................... - -
--------- ---------
Operating Income - Mineral Products as adjusted.... $ 15.7 $ 13.6
========= =========

Total segment operating income as adjusted......... $ 143.2 $ 132.9
Unallocated corporate office items per GAAP........ (0.6) (1.3)
--------- ---------
Operating income as adjusted....................... $ 142.6 $ 131.6
========= =========

(1) Non-GAAP adjustments in the first nine months of 2005 represent $14.4
million of other operating charges related to a program for the
restructuring and consolidation of production capacity in the food
ingredients product line within the specialty chemicals segment,
including a $10.5 million non-cash charge for the impairment of fixed
assets at one of our domestic manufacturing facilities. See "Other
Operating Charges" above.

Specialty Chemicals

Sales in the first nine months of 2005 were $548.6 million compared with
$533.0 million for the first nine months of 2004. The 3% increase in sales was
primarily due to the favorable impact of the weaker U.S. dollar ($7.0 million),
primarily in Europe, and, to a lesser extent, higher unit volumes and pricing.

The specialty chemicals segment recorded operating income of $96.8 million
in the first nine months of 2005. On a comparable basis, excluding the
aforementioned impairment and other operating charges of $14.4 million in this
year's first nine months, operating income was $111.2 million compared with
$121.6 million in the first nine months of 2004. The lower operating income was
primarily attributable to higher raw material and energy costs ($19.1 million),
partially offset by the favorable impact of the weaker U.S. dollar ($2.8
million).

Industrial Chemicals

Sales in the first nine months of 2005 were $197.7 million compared
with $148.3 million in the same period in 2004. The 33% increase in sales
resulted from favorable pricing ($30.9 million), higher unit volumes ($15.1
million), including the impact of the first quarter 2005 acquisition of the
Lima, Ohio production facility and, to a lesser extent, the favorable effect of
the weaker U.S. dollar ($3.4 million).

The industrial chemicals segment recorded operating income of $16.3 million
in the first nine months of 2005 compared with an operating loss of $2.3 million
in the first nine months of 2004. The industrial chemicals segment's improved
pricing more than offset higher raw material and energy costs (totaling $15.2
million). The segment's improved performance was also favorably impacted by
higher unit volumes and an improved product mix (totaling $8.8 million),
partially offset by $2.4 million of one-time integration costs in connection
with the Lima acquisition.

Mineral Products

Sales for the mineral products segment for the first nine months of
2005 were $119.9 million compared with $100.0 million for the first nine months
of 2004. The 20% increase in sales was due to higher unit volumes ($12.6
million), as a result of industry-wide growth, and favorable pricing and
included 12% higher sales to BMCA, an affiliate.

Operating income for the mineral products segment was $15.7 million in the
first nine months of 2005 compared with $13.6 million for the first nine months
of 2004. The 15% improvement in operating income resulted from favorable pricing
($7.3 million) and the favorable impact of higher unit volumes, partially offset
by increased raw material and energy costs (totaling $7.6 million) and higher
freight and distribution expenses.

LIQUIDITY AND FINANCIAL CONDITION

Cash Flows and Cash Position

During the first nine months of 2005, our net cash outflow before
financing activities was $81.3 million, including the reinvestment of $125.1
million for capital programs and acquisitions, offset by $43.8 million of cash
generated from operations.

Operating Activities. Net cash generated from operating activities totaled
$43.8 million for the first nine months of 2005, which included a cash outflow
of $65.2 million for additional working capital. The additional working capital
cash outlay included a $39.0 million increase in receivables as a result of
higher sales and a $35.7 million increase in inventories to support our sales
growth, partially offset by a $9.8 million net increase in payables and accrued
liabilities.

Investing Activities. Net cash used in investing activities in the first
nine months of 2005 totaled $125.1 million for capital expenditures and
acquisitions. Capital expenditures in the first nine months of 2005 included
$33.6 million for the purchase of equipment at our Freetown, Massachusetts
facility. We entered into an operating lease in 1998 for a sale-leaseback
transaction related to this equipment. The lease had an initial term of four
years and, at our option, up to three one-year renewal periods. The lease
provided for a substantial guaranteed payment by us, adjusted at the end of each
renewal period, and included purchase and return options at fair market values
determined at the inception of the lease. We had the right to exercise a
purchase option with respect to the leased equipment, or the equipment could be
returned to the lessor and sold to a third party. We exercised the purchase
option in the first quarter of 2005 for a purchase price of $33.6 million. Our
total capital expenditures for the year 2005 are expected to be approximately
$120 million.

In March 2005, we acquired a 1,4-butanediol ("BDO") production facility in
Lima, Ohio, and related working capital. BDO is a key building block for many of
the core specialty chemicals that we market for pharmaceutical, personal care,
food, beverage, coatings, oil field and other market applications. The
preliminary purchase price of the acquisition has been allocated to the
estimated fair value of the assets acquired pending the determination of any
additional contingent consideration. This acquisition is not expected to be
material to our results of operations in 2005.

Financing Activities. Net cash provided by financing activities in the
first nine months of 2005 totaled $69.3 million, principally attributable to
$140.0 million of capital contributions from our parent company and $38.0
million of revolving credit borrowings, net of repayments, under our senior
credit facilities, partially offset by $107.0 million of cash dividends paid to
our parent company. Financing activities in the first nine months of 2005 also
included $1.7 million of repayments of long-term debt.

As a result of the foregoing factors, cash and cash equivalents decreased
by $13.4 million during the first nine months of 2005 to $19.6 million.

Current Maturities of Long-Term Debt

As of October 2, 2005, our current maturities of long-term debt, scheduled
to be repaid during the twelve-month period ended September 2006, totaled $2.8
million, including $2.5 million related to the term loan under our senior credit
facilities.

Contingencies

See Note 12 to consolidated financial statements for information regarding
contingencies.

Contractual Obligations

In our Annual Report on Form 10-K for the fiscal year ended December 31,
2004, we presented information summarizing certain of our long-term contractual
obligations as of December 31, 2004. Set forth below is a table summarizing
additional long-term contractual obligations as of October 2, 2005 relating to
our senior credit facilities and benefit plans. We intend to include these
additional line items and footnotes in our contractual obligations table in our
future Annual Reports on Form 10-K.

Payments Due by Period
--------------------------------------------------------
Less
than 1-3 4-5 After
Total 1 Year Years Years 5 Years
------ ------- ------- ------ -------
(Millions)

Estimated interest payments on senior
credit facilities (1)................. $ 84.7 $ 14.3 $ 34.0 $ 32.2 $ 4.2
Planned funding of pension and other
postretirement benefit obligations (2) 9.1 0.7 1.3 1.1 6.0
Estimated non-qualified defined benefit
retirement plan payments (2).......... 12.7 0.9 1.9 1.9 8.0

(1) Based on an assumed interest rate of LIBOR plus 2.0%, ranging from
an average rate of 4.9% in 2005 to 8.1% in 2010 and 2011 on estimated
average term loan balances outstanding each year on a total loan
balance of $246.3 million at October 2, 2005 and scheduled payments
of $2.5 million per year through 2009, $176.9 million in 2010 and
$58.7 million in the first quarter of 2011.

(2) We assume no planned funding of our hourly retirement plan. For other
postretirement benefit obligations totaling $9.1 million at October
2, 2005, and for non-qualified defined benefit retirement plan
obligations totaling $12.7 million at October 2, 2005, the payments
each year are based on actuarially computed estimates.

We have an acetylene supply contract for our requirements of acetylene
delivery via pipeline to our Calvert City, Kentucky facility. The current term
of this contract expires December 31, 2009 and allows us, at our sole option, to
extend the agreement for two additional five-year terms. We are required by the
contract to pay a monthly non-cancelable facility fee. Pricing under the
contract is on a fixed basis with escalators related to changes in actual costs
and changes in the Producer Price Index.

In 2004, we entered into a long-term requirements contract for acetylene at
our Texas City, Texas facility. Under this contract, we are obligated to
purchase specified quantities of acetylene through the end of 2013. Pricing
under this contract is on a fixed basis with escalators related to changes in
actual costs and changes in the Producer Price Index.

The annual unconditional purchase obligation related to the long-term
acetylene supply contract at the Texas City plant, together with the
non-cancelable facility fee associated with the acetylene contract for the
Calvert City plant, is $5.1 million.

In March 2005, we entered into a long-term contract with an
international company for us to purchase 100% of our global requirements of a
product in the specialty chemicals business that we currently manufacture.
Subject to limited conditions and commencing no later than April 2006, for a
period of five years our annual purchase obligation related to this long-term
supply contract will be approximately $6.5 million. In the event that we do not
meet the annual purchase obligation, we must pay a penalty equal to 30% of the
price of the volume shortfall.

As previously discussed, in March 2005, we acquired a BDO production
facility in Lima, Ohio. As part of this acquisition, we assumed responsibility
for a long-term supply agreement for the purchase of 100% of our hydrogen gas
requirements for the Lima facility from a supplier located within the same
complex as our BDO production facility. The supply agreement was originally
entered into in 1999 and has a term of 15 years beginning in March 2000. We are
required to pay a minimum monthly charge (currently $3.1 million on an
annualized basis), which increases at the rate of 3.5% per year for the
remainder of the term of the agreement.

Recent Accounting Pronouncements

In November 2004, the Financial Accounting Standards Board, which we refer
to as "FASB," issued SFAS, No. 151, "Inventory Costs," an amendment of
Accounting Research Bulletin, which we refer to as "ARB," No. 43, Chapter 4,
which discussed the general principles applicable to the pricing of inventory.
SFAS No. 151 amends ARB No. 43, Chapter 4, to clarify that abnormal amounts of
idle facility expense, freight, handling costs, and spoilage should be
recognized as current-period charges. In addition, SFAS No. 151 requires that
allocation of fixed production overheads to the costs of conversion be based on
the normal capacity of the production facilities. SFAS No. 151 will be effective
for inventory costs incurred during fiscal years beginning after June 15, 2005.
We do not expect the adoption of SFAS No. 151 to have a material effect on our
consolidated financial statements.

In December 2004, the FASB issued SFAS No. 153, "Exchanges of Nonmonetary
Assets," an amendment of Accounting Principles Board, which we refer to as
"APB," Opinion No. 29. SFAS No. 153 eliminates the exception from fair value
measurement for nonmonetary exchanges of similar productive assets and replaces
it with an exception for exchanges that do not have commercial substance. A
nonmonetary exchange has commercial substance if the entity's future cash flows
are expected to significantly change as a result of the exchange. SFAS No. 153
will be effective for nonmonetary asset exchanges occurring in fiscal reporting
periods beginning after June 15, 2005. We do not expect the adoption of SFAS No.
153 to have an immediate effect on our consolidated financial statements.

In December 2004, the FASB issued a revised SFAS No. 123, which we refer to
as "SFAS No. 123R," "Share-Based Payment." SFAS No. 123R requires that the cost
resulting from all share-based payment transactions be recognized in the
financial statements. SFAS No. 123R establishes fair value as the measurement
objective in accounting for share-based payment arrangements and requires all
entities to apply a fair-value-based

measurement method in accounting for share-based payment transactions with
employees. In February 2003, our indirect parent company, International
Specialty Products Inc., which we refer to as "ISP," completed a going private
transaction. As a result, stock-based compensation plans were terminated and
payments were made in accordance with the terms of the merger agreement. In
addition, we currently account for incentive units granted to our eligible
employees pursuant to ISP's 2000 Long-Term Incentive Plan and 2003 Executive
Long-Term Incentive Plan under the accounting prescribed by FASB Interpretation
No., which we refer to as "FIN" 28, "Accounting for Stock Appreciation Rights
and Other Variable Stock Option and Award Plans." FIN 28 requires an entity to
measure compensation as the amount by which the Book Value (as defined in the
plans) of the incentive units covered by the grant exceeds the option price or
value specified of such incentive units between the date of grant and the
measurement date, resulting in a change in the measure of compensation for the
right or award. Since compensation expense related to such incentive units is
currently included in our actual Consolidated Statements of Operations, we do
not expect SFAS No. 123R to have an impact on our consolidated
financial statements.

In December 2004, the FASB issued FASB Staff Position, which we refer to as
"FSP," Nos. FAS 109-1 and FAS 109-2, each as a result of the passage in October
2004 of the American Jobs Creation Act of 2004, which we refer to as the "Jobs
Act." FSP No. FAS 109-1 relates to a provision in the Jobs Act that provides a
tax deduction of up to 9 percent (when fully phased-in) on qualified production
activities. The FASB indicated in FSP No. FAS 109-1 that this deduction should
be accounted for as a special deduction in accordance with SFAS No. 109,
"Accounting for Income Taxes," rather than as a tax rate reduction. This FSP is
effective upon issuance. We do not expect the adoption of this FSP to have a
material effect on our 2005 consolidated financial statements.

FSP No. FAS 109-2 relates to a provision in the Jobs Act that introduces a
special one-time dividends received deduction on the repatriation of certain
foreign earnings to a U.S. taxpayer, provided certain criteria are met. FSP No.
FAS 109-2 was effective upon issuance. This FSP will not have an impact on our
consolidated financial statements.

In March 2005, the FASB issued FIN 47, "Accounting for Conditional Asset
Retirement Obligations," an interpretation of SFAS No. 143, "Accounting for
Asset Retirement Obligations." SFAS No. 143 states that an entity shall
recognize the fair value of a liability for an asset retirement obligation
("ARO") in the period in which it is incurred if a reasonable estimate of fair
value can be made. The term "conditional asset retirement obligation" refers to
a legal obligation to perform an asset retirement activity in which the timing
and/or method of settlement are conditional on a future event that may or may
not be within the control of the entity. FIN 47 states that if an entity has
sufficient information to reasonably estimate the fair value of an ARO, it must
recognize a liability at the time the liability is incurred. An entity would
have sufficient information to apply an expected present value and therefore an
ARO would be reasonably estimable if either of the following conditions exist:
(a) the settlement date and method of settlement for the ARO have been specified
by others, such as by law, regulation or contract or (b) the information is
available to reasonably estimate the settlement date or the range of potential
settlement dates, the method of settlement, and the probabilities associated
with the potential settlement dates and methods of settlements. FIN 47 will be
effective for the Company as of

December 31, 2005. We are currently reviewing our AROs to determine the
potential impact of FIN 47 on our consolidated financial statements, and, at
this time, we do not believe that FIN 47 will have a material impact on our
consolidated financial statements.

In May 2005, the FASB issued SFAS No. 154, "Accounting Changes and Error
Corrections." SFAS No. 154 eliminates the requirement in APB Opinion No. 20,
"Accounting Changes," to include the cumulative effect of changes in accounting
principles in the Consolidated Statement of Operations in the period of change.
Instead, SFAS No. 154 requires that changes in accounting principles be
retrospectively applied, whereby the new accounting principle is applied to
prior accounting periods as if that principle had always been used. SFAS No. 154
also redefines "restatement" as the revision of previously issued financial
statements to reflect the correction of an error. SFAS No. 154 is effective for
accounting changes and corrections of errors made in fiscal years beginning
after December 15, 2005, although early adoption is permitted for accounting
changes and correction of errors made after the date SFAS No. 154 was issued.
SFAS No. 154 does not change the transition provisions of any existing
accounting pronouncements. We will adopt the provisions of SFAS No. 154 as of
January 1, 2006.

* * *

Forward-looking Statements

This quarterly report on Form 10-Q contains both historical and
forward-looking statements. All statements other than statements of historical
fact are, or may be deemed to be, forward-looking statements within the meaning
of section 27A of the Securities Act of 1933 and section 21E of the Securities
Exchange Act of 1934. These forward-looking statements are only predictions and
generally can be identified by use of statements that include phrases such as
"believe", "expect", "anticipate", "intend", "plan", "foresee" or other words or
phrases of similar import. Similarly, statements that describe our objectives,
plans or goals also are forward-looking statements. Our operations are subject
to certain risks and uncertainties that could cause actual results to differ
materially from those contemplated by the relevant forward-looking statement.
The forward-looking statements included herein are made only as of the date of
this quarterly report on Form 10-Q and we undertake no obligation to publicly
update such forward-looking statements to reflect subsequent events or
circumstances. No assurances can be given that projected results or events will
be achieved.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES
ABOUT MARKET RISK

Reference is made to Management's Discussion and Analysis of Financial
Condition and Results of Operations in our Annual Report on Form 10-K for the
fiscal year ended December 31, 2004, for a discussion of "Market-Sensitive
Instruments and Risk Management." At December 31, 2004 and October 2, 2005,
there were no equity-related financial instruments employed by us to reduce
market risk.

ITEM 4. CONTROLS AND PROCEDURES

Disclosure Controls and Procedures: Our management, with the
participation of the Chief Executive Officer and Chief Financial Officer,
conducted an evaluation of the effectiveness of our disclosure controls and
procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the
Securities Exchange Act of 1934, as amended (the "Exchange Act")) as of the end
of the period covered by this report. Based on this evaluation, the Chief
Executive Officer and Chief Financial Officer have each concluded that, as of
the end of such period, our disclosure controls and procedures are effective in
recording, processing, summarizing and reporting, on a timely basis, information
required to be disclosed by us in the reports filed, furnished or submitted
under the Exchange Act. The Chief Executive Officer and Chief Financial Officer
concluded that our disclosure controls and procedures are also effective to
ensure that information required to be disclosed in the reports that we file or
submit under the Exchange Act is accumulated and communicated to our management,
including our Chief Executive Officer and Chief Financial Officer, to allow
timely decisions regarding required disclosures.

Internal Control Over Financial Reporting: There were no significant
changes in our internal control over financial reporting identified in
management's evaluation during the fiscal quarter to which this report relates
that have materially affected, or are reasonably likely to materially affect,
our internal control over financial reporting.

PART II
OTHER INFORMATION

ITEM 6. EXHIBITS

Exhibits:

Exhibit Number
--------------

31.1 Rule 13a-14(a)/Rule 15d-14(a) Certification of the Chief Executive
Officer.

31.2 Rule 13a-14(a)/Rule 15d-14(a) Certification of the Chief Financial
Officer.

32.1 Certification of the Chief Executive Officer and Chief Financial
Officer pursuant to 18 U.S.C. Section 1350.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, each
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.

ISP CHEMCO INC.
ISP CHEMICALS INC.
ISP MINERALS INC.
ISP TECHNOLOGIES INC.

DATE: November 16, 2005 BY: /s/ Roger J. Cope
----------------- -----------------

Roger J. Cope
Senior Vice President and
Interim Chief Financial Officer
(Principal Financial Officer)

DATE: November 16, 2005 BY: /s/Kenneth M. McHugh
----------------- --------------------

Kenneth M. McHugh
Vice President and Controller
(Principal Accounting Officer)